UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM N-Q

QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY

Investment Company Act file number 811-3010

Fidelity Advisor Series VII
(Exact name of registrant as specified in charter)

245 Summer St., Boston, Massachusetts 02210
(Address of principal executive offices)       (Zip code)

Scott C. Goebel, Secretary

245 Summer St.

Boston, Massachusetts 02210
(Name and address of agent for service)

Registrant's telephone number, including area code: 617-563-7000

Date of fiscal year end:

July 31

 

 

Date of reporting period:

April 30, 2013

Item 1. Schedule of Investments

Quarterly Holdings Report

for

Fidelity Advisor ® Consumer Discretionary Fund
Class A
Class T
Class B
Class C
Institutional Class


April 30, 2013

1.800322.109
AFCI-QTLY-0613

Investments April 30, 2013 (Unaudited)

Showing Percentage of Net Assets

Common Stocks - 99.7%

Shares

Value

AUTO COMPONENTS - 0.7%

Auto Parts & Equipment - 0.7%

Delphi Automotive PLC

9,934

$ 459,050

COMMERCIAL SERVICES & SUPPLIES - 0.5%

Office Services & Supplies - 0.5%

Interface, Inc.

22,400

374,976

DISTRIBUTORS - 2.1%

Distributors - 2.1%

LKQ Corp. (a)

59,700

1,437,576

DIVERSIFIED CONSUMER SERVICES - 0.1%

Specialized Consumer Services - 0.1%

Ascent Capital Group, Inc. (a)

1,400

93,086

HOTELS, RESTAURANTS & LEISURE - 12.5%

Casinos & Gaming - 1.0%

Wynn Resorts Ltd.

4,981

683,891

Hotels, Resorts & Cruise Lines - 1.0%

Wyndham Worldwide Corp.

11,969

719,098

Restaurants - 10.5%

BJ's Restaurants, Inc. (a)

3,434

117,786

Bloomin' Brands, Inc.

30,042

653,414

Buffalo Wild Wings, Inc. (a)

5,940

534,600

Chipotle Mexican Grill, Inc. (a)

2,049

744,176

Domino's Pizza, Inc.

17,208

949,882

Panera Bread Co. Class A (a)

100

17,723

Starbucks Corp.

30,394

1,849,171

Texas Roadhouse, Inc. Class A

10,213

240,006

Yum! Brands, Inc.

31,408

2,139,513

 

7,246,271

TOTAL HOTELS, RESTAURANTS & LEISURE

8,649,260

HOUSEHOLD DURABLES - 2.1%

Homebuilding - 0.7%

NVR, Inc. (a)

460

473,800

Housewares & Specialties - 1.4%

Jarden Corp. (a)

21,869

984,324

TOTAL HOUSEHOLD DURABLES

1,458,124

INTERNET & CATALOG RETAIL - 4.9%

Catalog Retail - 2.1%

Liberty Media Corp. Interactive Series A (a)

68,768

1,464,071

Internet Retail - 2.8%

Amazon.com, Inc. (a)

2,794

709,145

priceline.com, Inc. (a)

1,710

1,190,143

 

1,899,288

TOTAL INTERNET & CATALOG RETAIL

3,363,359

 

Shares

Value

LEISURE EQUIPMENT & PRODUCTS - 2.7%

Leisure Products - 2.7%

Brunswick Corp.

30,100

$ 952,966

Mattel, Inc.

19,495

890,142

 

1,843,108

MEDIA - 26.4%

Broadcasting - 3.2%

Discovery Communications, Inc. (a)

13,600

1,071,952

Liberty Media Corp. Class A (a)

10,081

1,158,105

 

2,230,057

Cable & Satellite - 8.2%

Comcast Corp. Class A

132,386

5,467,542

DISH Network Corp. Class A

4,935

193,403

 

5,660,945

Movies & Entertainment - 15.0%

News Corp. Class A

104,511

3,236,706

The Walt Disney Co.

68,338

4,294,360

Time Warner, Inc.

46,990

2,809,062

 

10,340,128

TOTAL MEDIA

18,231,130

MULTILINE RETAIL - 4.4%

General Merchandise Stores - 4.4%

Dollar General Corp. (a)

34,161

1,779,446

Dollar Tree, Inc. (a)

27,033

1,285,689

 

3,065,135

PROFESSIONAL SERVICES - 0.5%

Research & Consulting Services - 0.5%

Nielsen Holdings B.V.

9,720

336,506

SPECIALTY RETAIL - 33.1%

Apparel Retail - 9.3%

Abercrombie & Fitch Co. Class A

9,991

495,154

American Eagle Outfitters, Inc.

62,010

1,206,095

Ascena Retail Group, Inc. (a)

3,100

57,350

DSW, Inc. Class A

6,100

403,332

L Brands, Inc.

22,241

1,121,169

Ross Stores, Inc.

19,525

1,290,017

TJX Companies, Inc.

37,473

1,827,558

 

6,400,675

Automotive Retail - 4.7%

AutoZone, Inc. (a)

1,900

777,271

CarMax, Inc. (a)

15,750

725,130

O'Reilly Automotive, Inc. (a)

16,341

1,753,716

 

3,256,117

Home Improvement Retail - 5.7%

Home Depot, Inc.

18,445

1,352,941

Lowe's Companies, Inc.

67,601

2,597,230

 

3,950,171

Common Stocks - continued

Shares

Value

SPECIALTY RETAIL - CONTINUED

Homefurnishing Retail - 3.5%

Bed Bath & Beyond, Inc. (a)

14,434

$ 993,059

Williams-Sonoma, Inc.

25,958

1,393,425

 

2,386,484

Specialty Stores - 9.9%

Cabela's, Inc. Class A (a)

23,017

1,477,691

Dick's Sporting Goods, Inc.

19,763

950,600

Hibbett Sports, Inc. (a)

5,806

318,459

PetSmart, Inc.

19,689

1,343,577

Sally Beauty Holdings, Inc. (a)

33,800

1,016,028

Tractor Supply Co.

9,771

1,047,158

Ulta Salon, Cosmetics & Fragrance, Inc.

7,944

696,292

 

6,849,805

TOTAL SPECIALTY RETAIL

22,843,252

TEXTILES, APPAREL & LUXURY GOODS - 9.7%

Apparel, Accessories & Luxury Goods - 5.6%

Coach, Inc.

14,950

879,957

Hanesbrands, Inc.

24,410

1,224,406

PVH Corp.

3,537

408,205

VF Corp.

7,632

1,360,175

 

3,872,743

Footwear - 4.1%

NIKE, Inc. Class B

32,632

2,075,395

 

Shares

Value

Steven Madden Ltd. (a)

6,800

$ 330,684

Wolverine World Wide, Inc.

9,200

439,484

 

2,845,563

TOTAL TEXTILES, APPAREL & LUXURY GOODS

6,718,306

TOTAL COMMON STOCKS

(Cost $53,968,340)


68,872,868

Money Market Funds - 0.4%

 

 

 

 

Fidelity Cash Central Fund, 0.13% (b)
(Cost $310,110)

310,110


310,110

TOTAL INVESTMENT PORTFOLIO - 100.1%

(Cost $54,278,450)

69,182,978

NET OTHER ASSETS (LIABILITIES) - (0.1)%

(87,977 )

NET ASSETS - 100%

$ 69,095,001

Legend

(a) Non-income producing

(b) Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.

Affiliated Central Funds

Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:

Fund

Income earned

Fidelity Cash Central Fund

$ 858

Fidelity Securities Lending Cash Central Fund

1,255

Total

$ 2,113

Other Information

All investments are categorized as Level 1 under the Fair Value Hierarchy. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. For more information on valuation inputs, please refer to the Investment Valuation section at the end of this listing.

Income Tax Information

At April 30, 2013, the cost of investment securities for income tax purposes was $54,573,909. Net unrealized appreciation aggregated $14,609,069, of which $14,948,393 related to appreciated investment securities and $339,324 related to depreciated investment securities.

Investment Valuation

Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. In accordance with valuation policies and procedures approved by the Board of Trustees (the Board), the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Fidelity Management & Research Company (FMR) Fair Value Committee (the Committee), in accordance with procedures adopted by the Fund's Board. Factors used in determining fair value vary by investment type and may include market or investment specific events. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund's valuation policies and procedures and is responsible for approving and reporting to the Board all fair value determinations. The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels: Level 1 - quoted prices in active markets for identical investments: Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds etc.): Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available). Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the Fund's investments by major category are as follows:

Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy in these circumstances. Utilizing these techniques may result in transfers between Level 1 and Level 2.

Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value each business day and are categorized as Level 1 in the hierarchy.

For additional information on the Fund's policy regarding valuation of investments and other significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.

Quarterly Report

The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please visit advisor.fidelity.com or call Fidelity at 1-877-208-0098 for a free copy of the fund's most recent prospectus and annual report.

Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.

Quarterly Report

Quarterly Holdings Report

for

Fidelity Advisor ® Real Estate Fund
Class A
Class T
Class B
Class C
Institutional Class

April 30, 2013

1.800329.109
ARE-QTLY-0613

Investments April 30, 2013 (Unaudited)

Showing Percentage of Net Assets

Common Stocks - 97.0%

Shares

Value

HEALTH CARE PROVIDERS & SERVICES - 2.5%

Health Care Facilities - 2.5%

Brookdale Senior Living, Inc. (a)

440,185

$ 11,352,371

Emeritus Corp. (a)

402,437

10,342,631

TOTAL HEALTH CARE FACILITIES

21,695,002

REAL ESTATE INVESTMENT TRUSTS - 93.1%

REITs - Apartments - 15.7%

Apartment Investment & Management Co. Class A

152,866

4,755,661

AvalonBay Communities, Inc.

121,282

16,135,357

Camden Property Trust (SBI)

429,374

31,060,915

Education Realty Trust, Inc.

1,459,976

16,045,136

Equity Residential (SBI)

385,712

22,394,439

Essex Property Trust, Inc.

172,203

27,044,481

Home Properties, Inc.

307,670

19,832,408

TOTAL REITS - APARTMENTS

137,268,397

REITs - Health Care Facilities - 13.0%

Aviv REIT, Inc.

29,600

760,424

HCP, Inc.

602,695

32,123,644

Health Care REIT, Inc.

210,769

15,801,352

Ventas, Inc.

808,320

64,366,522

TOTAL REITS - HEALTH CARE FACILITIES

113,051,942

REITs - Hotels - 5.1%

Chesapeake Lodging Trust

682,695

16,152,564

Host Hotels & Resorts, Inc.

892,634

16,308,423

Sunstone Hotel Investors, Inc. (a)

992,491

12,316,813

TOTAL REITS - HOTELS

44,777,800

REITs - Industrial Buildings - 16.1%

DuPont Fabros Technology, Inc.

387,400

9,739,236

First Industrial Realty Trust, Inc.

557,839

10,007,632

First Potomac Realty Trust

282,870

4,525,920

Prologis, Inc.

1,289,757

54,105,306

Common Stocks - continued

Shares

Value

REAL ESTATE INVESTMENT TRUSTS - CONTINUED

REITs - Industrial Buildings - continued

Public Storage

372,194

$ 61,412,010

Terreno Realty Corp.

49,200

925,944

TOTAL REITS - INDUSTRIAL BUILDINGS

140,716,048

REITs - Malls - 16.6%

CBL & Associates Properties, Inc.

322,648

7,788,723

General Growth Properties, Inc.

1,079,000

24,514,880

Simon Property Group, Inc.

599,378

106,731,237

The Macerich Co.

85,693

6,002,795

TOTAL REITS - MALLS

145,037,635

REITs - Management/Investment - 1.4%

Coresite Realty Corp.

20,700

748,926

Equity Lifestyle Properties, Inc.

23,300

1,893,125

Retail Properties America, Inc.

369,250

5,653,218

Weyerhaeuser Co.

130,700

3,987,657

TOTAL REITS - MANAGEMENT/INVESTMENT

12,282,926

REITs - Mobile Home Parks - 0.7%

Sun Communities, Inc.

119,662

6,120,711

REITs - Office Buildings - 17.0%

Alexandria Real Estate Equities, Inc.

328,684

23,918,335

Boston Properties, Inc.

309,649

33,884,890

Cousins Properties, Inc.

986,200

10,769,304

Douglas Emmett, Inc.

670,400

17,544,368

Highwoods Properties, Inc. (SBI)

332,641

13,648,260

Piedmont Office Realty Trust, Inc. Class A

529,000

10,855,080

SL Green Realty Corp.

414,565

37,601,046

TOTAL REITS - OFFICE BUILDINGS

148,221,283

REITs - Shopping Centers - 7.5%

Acadia Realty Trust (SBI)

328,254

9,371,652

Cedar Shopping Centers, Inc.

737,973

4,730,407

Equity One, Inc.

787,895

20,083,444

Excel Trust, Inc.

101,325

1,543,180

Glimcher Realty Trust

1,244,964

15,611,849

Common Stocks - continued

Shares

Value

REAL ESTATE INVESTMENT TRUSTS - CONTINUED

REITs - Shopping Centers - continued

Kite Realty Group Trust

738,031

$ 4,871,005

Vornado Realty Trust

104,416

9,142,665

TOTAL REITS - SHOPPING CENTERS

65,354,202

TOTAL REAL ESTATE INVESTMENT TRUSTS

812,830,944

REAL ESTATE MANAGEMENT & DEVELOPMENT - 1.4%

Real Estate Operating Companies - 1.0%

Forest City Enterprises, Inc. Class A (a)

477,467

8,914,309

Real Estate Services - 0.4%

CBRE Group, Inc. (a)

127,131

3,079,113

TOTAL REAL ESTATE MANAGEMENT & DEVELOPMENT

11,993,422

TOTAL COMMON STOCKS

(Cost $640,895,314)


846,519,368

Money Market Funds - 3.8%

 

 

 

 

Fidelity Cash Central Fund, 0.13% (b)
(Cost $33,402,961)

33,402,961


33,402,961

TOTAL INVESTMENT PORTFOLIO - 100.8%

(Cost $674,298,275)

879,922,329

NET OTHER ASSETS (LIABILITIES) - (0.8)%

(6,969,816 )

NET ASSETS - 100%

$ 872,952,513

Legend

(a) Non-income producing

(b) Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.

Affiliated Central Funds

Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:

Fund

Income earned

Fidelity Cash Central Fund

$ 27,412

Fidelity Securities Lending Cash Central Fund

3,523

Total

$ 30,935

Other Information

All investments are categorized as Level 1 under the Fair Value Hierarchy. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. For more information on valuation inputs, please refer to the Investment Valuation section at the end of this listing.

Income Tax Information

At April 30, 2013, the cost of investment securities for income tax purposes was $679,885,821. Net unrealized appreciation aggregated $200,036,508, of which $204,089,085 related to appreciated investment securities and $4,052,577 related to depreciated investment securities.

Investment Valuation

Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. In accordance with valuation policies and procedures approved by the Board of Trustees (the Board), the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Fidelity Management & Research Company (FMR) Fair Value Committee (the Committee), in accordance with procedures adopted by the Fund's Board. Factors used in determining fair value vary by investment type and may include market or investment specific events. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund's valuation policies and procedures and is responsible for approving and reporting to the Board all fair value determinations. The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels: Level 1 - quoted prices in active markets for identical investments: Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds etc.): Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available). Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the Fund's investments by major category are as follows:

Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy in these circumstances. Utilizing these techniques may result in transfers between Level 1 and Level 2.

Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value each business day and are categorized as Level 1 in the hierarchy.

For additional information on the Fund's policy regarding valuation of investments and other significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.

Quarterly Report

The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please visit advisor.fidelity.com or call Fidelity at 1-877-208-0098 for a free copy of the fund's most recent prospectus and annual report.

Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC

or an affiliate.

Quarterly Report

Quarterly Holdings Report

for

Fidelity Advisor ® Communications Equipment Fund

Class A
Class T
Class B
Class C
Institutional Class


April 30, 2013

1.800324.109
AFDC-QTLY-0613

Investments April 30, 2013 (Unaudited)

Showing Percentage of Net Assets

Common Stocks - 99.1%

Shares

Value

COMMUNICATIONS EQUIPMENT - 85.8%

Communications Equipment - 85.8%

ADTRAN, Inc.

9,000

$ 189,000

ADVA AG Optical Networking (a)

8,228

39,540

Alcatel-Lucent SA sponsored ADR (a)

174,457

239,006

Anaren, Inc. (a)

3,000

70,230

Aruba Networks, Inc. (a)

1,240

27,888

Brocade Communications Systems, Inc. (a)

51,959

302,401

Cisco Systems, Inc.

87,924

1,839,370

Comtech Telecommunications Corp.

3,600

88,596

F5 Networks, Inc. (a)

4,165

318,331

Finisar Corp. (a)(d)

15,059

193,358

Harris Corp.

2,500

115,500

Infinera Corp. (a)

20,000

168,400

InterDigital, Inc.

1,700

75,497

JDS Uniphase Corp. (a)

2,300

31,050

Juniper Networks, Inc. (a)

29,788

492,991

Motorola Solutions, Inc.

5,347

305,848

NETGEAR, Inc. (a)

5,900

175,761

Nokia Corp. sponsored ADR (d)

35,105

118,655

Plantronics, Inc.

2,300

100,786

Polycom, Inc. (a)

29,799

312,890

QUALCOMM, Inc.

25,481

1,570,139

Radware Ltd. (a)

4,000

59,960

Research In Motion Ltd. (a)(d)

21,600

351,864

Riverbed Technology, Inc. (a)

14,658

217,818

Sonus Networks, Inc. (a)

43,900

92,190

Symmetricom, Inc. (a)

15,200

79,040

Telefonaktiebolaget LM Ericsson (B Shares) sponsored ADR

43,220

532,038

ViaSat, Inc. (a)

3,400

164,798

Wi-Lan, Inc.

16,800

66,370

 

8,339,315

COMPUTERS & PERIPHERALS - 3.0%

Computer Hardware - 3.0%

Apple, Inc.

500

221,375

Super Micro Computer, Inc. (a)

7,100

68,302

 

289,677

ELECTRONIC EQUIPMENT & COMPONENTS - 3.9%

Electronic Manufacturing Services - 3.3%

Fabrinet (a)

4,600

63,158

Flextronics International Ltd. (a)

13,800

98,670

TE Connectivity Ltd.

3,600

156,780

 

318,608

Technology Distributors - 0.6%

Arrow Electronics, Inc. (a)

1,400

54,922

TOTAL ELECTRONIC EQUIPMENT & COMPONENTS

373,530

 

Shares

Value

IT SERVICES - 1.8%

IT Consulting & Other Services - 1.8%

Amdocs Ltd.

4,900

$ 174,930

SEMICONDUCTORS & SEMICONDUCTOR EQUIPMENT - 3.7%

Semiconductors - 3.7%

Altera Corp.

4,100

131,241

Analog Devices, Inc.

1,800

79,182

Broadcom Corp. Class A

1,900

68,400

GSI Technology, Inc. (a)

6,500

40,560

Skyworks Solutions, Inc. (a)

1,900

41,933

 

361,316

SOFTWARE - 0.9%

Application Software - 0.5%

BroadSoft, Inc. (a)

2,000

51,120

Systems Software - 0.4%

Allot Communications Ltd. (a)

3,500

39,620

TOTAL SOFTWARE

90,740

TOTAL COMMON STOCKS

(Cost $9,579,623)


9,629,508

Money Market Funds - 4.9%

 

 

 

 

Fidelity Cash Central Fund, 0.13% (b)

85,189

85,189

Fidelity Securities Lending Cash Central Fund, 0.12% (b)(c)

391,125

391,125

TOTAL MONEY MARKET FUNDS

(Cost $476,314)


476,314

TOTAL INVESTMENT PORTFOLIO - 104.0%

(Cost $10,055,937)

10,105,822

NET OTHER ASSETS (LIABILITIES) - (4.0)%

(386,644 )

NET ASSETS - 100%

$ 9,719,178

Legend

(a) Non-income producing

(b) Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.

(c) Investment made with cash collateral received from securities on loan.

(d) Security or a portion of the security is on loan at period end.

Affiliated Central Funds

Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:

Fund

Income earned

Fidelity Cash Central Fund

$ 527

Fidelity Securities Lending Cash Central Fund

10,170

Total

$ 10,697

Other Information

All investments are categorized as Level 1 under the Fair Value Hierarchy. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. For more information on valuation inputs, please refer to the Investment Valuation section at the end of this listing.

Income Tax Information

At April 30, 2013, the cost of investment securities for income tax purposes was $10,192,292. Net unrealized depreciation aggregated $86,470, of which $1,045,923 related to appreciated investment securities and $1,132,393 related to depreciated investment securities.

Investment Valuation

Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. In accordance with valuation policies and procedures approved by the Board of Trustees (the Board), the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Fidelity Management & Research Company (FMR) Fair Value Committee (the Committee), in accordance with procedures adopted by the Fund's Board. Factors used in determining fair value vary by investment type and may include market or investment specific events. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund's valuation policies and procedures and is responsible for approving and reporting to the Board all fair value determinations. The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels: Level 1 - quoted prices in active markets for identical investments: Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds etc.): Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available). Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the Fund's investments by major category are as follows:

Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy in these circumstances. Utilizing these techniques may result in transfers between Level 1 and Level 2.

Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value each business day and are categorized as Level 1 in the hierarchy.

For additional information on the Fund's policy regarding valuation of investments and other significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.

Quarterly Report

The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please visit advisor.fidelity.com or call Fidelity at 1-877-208-0098 for a free copy of the fund's most recent prospectus and annual report.

Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.

Quarterly Report

Quarterly Holdings Report

for

Fidelity Advisor ® Utilities Fund
Class A
Class T
Class B
Class C
Institutional Class


April 30, 2013

1.800331.109
AFUG-QTLY-0613

Investments April 30, 2013 (Unaudited)

Showing Percentage of Net Assets

Common Stocks - 99.1%

Shares

Value

ELECTRIC UTILITIES - 44.1%

Electric Utilities - 44.1%

American Electric Power Co., Inc.

352,115

$ 18,109,274

Duke Energy Corp.

386,991

29,101,725

Edison International

211,923

11,401,457

FirstEnergy Corp.

359,782

16,765,841

ITC Holdings Corp.

35,580

3,281,188

Northeast Utilities

134,987

6,118,961

OGE Energy Corp.

137,535

9,961,660

Southern Co.

232,200

11,199,006

 

105,939,112

GAS UTILITIES - 3.8%

Gas Utilities - 3.8%

National Fuel Gas Co.

31,570

1,980,070

ONEOK, Inc.

104,734

5,379,138

Questar Corp.

68,652

1,743,074

 

9,102,282

INDEPENDENT POWER PRODUCERS & ENERGY TRADERS - 10.6%

Independent Power Producers & Energy Traders - 10.6%

Calpine Corp. (a)

247,790

5,384,477

NRG Energy, Inc.

339,675

9,466,742

The AES Corp.

765,667

10,612,145

 

25,463,364

MULTI-UTILITIES - 30.5%

Multi-Utilities - 30.5%

Ameren Corp.

228,600

8,286,750

CenterPoint Energy, Inc.

537,919

13,275,841

Dominion Resources, Inc.

190,500

11,750,040

NiSource, Inc.

287,663

8,839,884

PG&E Corp.

358,244

17,353,339

Sempra Energy

165,853

13,740,921

 

73,246,775

OIL, GAS & CONSUMABLE FUELS - 6.8%

Oil & Gas Storage & Transport - 6.8%

Cheniere Energy, Inc. (a)

102,889

2,930,279

 

Shares

Value

Enbridge, Inc.

122,700

$ 5,838,739

Spectra Energy Corp.

110,176

3,473,849

TransCanada Corp.

80,900

4,010,270

 

16,253,137

WATER UTILITIES - 3.3%

Water Utilities - 3.3%

American Water Works Co., Inc.

167,748

7,025,286

Companhia de Saneamento Basico do Estado de Sao Paulo (SABESP) sponsored ADR

69,900

999,570

 

8,024,856

TOTAL COMMON STOCKS

(Cost $206,561,670)


238,029,526

Money Market Funds - 1.4%

 

 

 

 

Fidelity Cash Central Fund, 0.13% (b)
(Cost $3,281,967)

3,281,967


3,281,967

TOTAL INVESTMENT PORTFOLIO - 100.5%

(Cost $209,843,637)

241,311,493

NET OTHER ASSETS (LIABILITIES) - (0.5)%

(1,210,410 )

NET ASSETS - 100%

$ 240,101,083

Legend

(a) Non-income producing

(b) Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.

Affiliated Central Funds

Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:

Fund

Income earned

Fidelity Cash Central Fund

$ 3,820

Fidelity Securities Lending Cash Central Fund

2,138

Total

$ 5,958

Other Information

All investments are categorized as Level 1 under the Fair Value Hierarchy. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. For more information on valuation inputs, please refer to the Investment Valuation section at the end of this listing.

Income Tax Information

At April 30, 2013, the cost of investment securities for income tax purposes was $210,001,895. Net unrealized appreciation aggregated $31,309,598, of which $31,410,714 related to appreciated investment securities and $101,116 related to depreciated investment securities.

Investment Valuation

Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. In accordance with valuation policies and procedures approved by the Board of Trustees (the Board), the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Fidelity Management & Research Company (FMR) Fair Value Committee (the Committee), in accordance with procedures adopted by the Fund's Board. Factors used in determining fair value vary by investment type and may include market or investment specific events. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund's valuation policies and procedures and is responsible for approving and reporting to the Board all fair value determinations. The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels: Level 1 - quoted prices in active markets for identical investments: Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds etc.): Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available). Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the Fund's investments by major category are as follows:

Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy in these circumstances. Utilizing these techniques may result in transfers between Level 1 and Level 2.

Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value each business day and are categorized as Level 1 in the hierarchy.

For additional information on the Fund's policy regarding valuation of investments and other significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.

Quarterly Report

The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please visit advisor.fidelity.com or call Fidelity at 1-877-208-0098 for a free copy of the fund's most recent prospectus and annual report.

Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.

Quarterly Report

Quarterly Holdings Report

for

Fidelity Advisor ® Health Care Fund
Class A
Class T
Class B
Class C
Institutional Class


April 30, 2013

1.800327.109
AFHC-QTLY-0613

Investments April 30, 2013 (Unaudited)

Showing Percentage of Net Assets

Common Stocks - 99.5%

Shares

Value

BIOTECHNOLOGY - 33.9%

Biotechnology - 33.9%

Achillion Pharmaceuticals, Inc. (a)

313,000

$ 2,360,020

Acorda Therapeutics, Inc. (a)

40,845

1,616,237

Alexion Pharmaceuticals, Inc. (a)

168,636

16,526,328

Amgen, Inc.

490,000

51,062,899

Biogen Idec, Inc. (a)

28,383

6,213,890

BioMarin Pharmaceutical, Inc. (a)

130,697

8,573,723

Biovitrum AB (a)

330,900

2,108,635

Discovery Laboratories, Inc. (a)(d)

428,038

723,384

Dynavax Technologies Corp. (a)

394,000

925,900

Elan Corp. PLC sponsored ADR (a)

158,000

1,848,600

Genomic Health, Inc. (a)

68,700

2,085,732

Gilead Sciences, Inc. (a)

928,734

47,031,090

Grifols SA ADR

212,687

6,642,215

Infinity Pharmaceuticals, Inc. (a)

87,200

3,757,448

Insmed, Inc. (a)

53,900

493,724

Intercept Pharmaceuticals, Inc.

16,400

558,420

Lexicon Pharmaceuticals, Inc. (a)

724,111

1,433,740

Medivation, Inc. (a)

140,000

7,379,400

Merrimack Pharmaceuticals, Inc. (a)

88,673

436,271

Momenta Pharmaceuticals, Inc. (a)

120,500

1,484,560

Neurocrine Biosciences, Inc. (a)

247,018

2,850,588

NPS Pharmaceuticals, Inc. (a)

171,000

2,296,530

Onyx Pharmaceuticals, Inc. (a)

150,000

14,220,000

Puma Biotechnology, Inc. (a)

62,194

2,001,403

Regeneron Pharmaceuticals, Inc. (a)

62,829

13,517,031

Spectrum Pharmaceuticals, Inc. (d)

179,500

1,330,095

Synageva BioPharma Corp. (a)

25,302

1,307,860

Synta Pharmaceuticals Corp. (a)(d)

123,300

1,263,825

Targacept, Inc. (a)

196,415

905,473

Theravance, Inc. (a)(d)

163,566

5,520,353

ZIOPHARM Oncology, Inc. (a)(d)

404,100

678,888

 

209,154,262

DIVERSIFIED CONSUMER SERVICES - 0.5%

Specialized Consumer Services - 0.5%

Carriage Services, Inc.

175,055

3,061,712

FOOD & STAPLES RETAILING - 2.4%

Drug Retail - 2.4%

CVS Caremark Corp.

174,846

10,172,540

Walgreen Co.

98,238

4,863,763

 

15,036,303

HEALTH CARE EQUIPMENT & SUPPLIES - 9.3%

Health Care Equipment - 7.5%

Boston Scientific Corp. (a)

1,993,801

14,933,569

Cardiovascular Systems, Inc. (a)

87,020

1,493,263

CONMED Corp.

115,800

3,628,014

Covidien PLC

67,523

4,310,668

Genmark Diagnostics, Inc. (a)

11,000

171,050

HeartWare International, Inc. (a)

19,705

1,915,326

 

Shares

Value

Insulet Corp. (a)

182,800

$ 4,613,872

Intuitive Surgical, Inc. (a)

7,500

3,692,175

Volcano Corp. (a)

197,200

4,001,188

Zeltiq Aesthetics, Inc. (a)

205,900

901,842

Zimmer Holdings, Inc.

88,400

6,758,180

 

46,419,147

Health Care Supplies - 1.8%

Derma Sciences, Inc. (a)

190,000

2,297,100

The Cooper Companies, Inc.

80,550

8,892,720

 

11,189,820

TOTAL HEALTH CARE EQUIPMENT & SUPPLIES

57,608,967

HEALTH CARE PROVIDERS & SERVICES - 16.4%

Health Care Distributors & Services - 3.6%

Amplifon SpA

245,163

1,262,412

McKesson Corp.

196,455

20,788,868

 

22,051,280

Health Care Facilities - 2.6%

Brookdale Senior Living, Inc. (a)

91,200

2,352,048

Emeritus Corp. (a)

102,000

2,621,400

Hanger, Inc. (a)

61,265

1,861,843

HCA Holdings, Inc.

115,800

4,619,262

NMC Health PLC

341,800

1,645,899

Raffles Medical Group Ltd.

308,000

855,208

Ramsay Health Care Ltd.

67,936

2,253,032

 

16,208,692

Health Care Services - 5.8%

BioScrip, Inc. (a)

333,900

4,627,854

Catamaran Corp. (a)

125,392

7,240,114

Express Scripts Holding Co. (a)

39,200

2,327,304

MEDNAX, Inc. (a)

121,800

10,807,314

Quest Diagnostics, Inc.

193,848

10,919,458

 

35,922,044

Managed Health Care - 4.4%

Aetna, Inc.

28,400

1,631,296

CIGNA Corp.

137,600

9,104,992

Humana, Inc.

124,832

9,251,300

Qualicorp SA (a)

125,000

1,217,044

UnitedHealth Group, Inc.

97,637

5,851,385

 

27,056,017

TOTAL HEALTH CARE PROVIDERS & SERVICES

101,238,033

HEALTH CARE TECHNOLOGY - 5.3%

Health Care Technology - 5.3%

athenahealth, Inc. (a)(d)

82,900

7,979,954

Cerner Corp. (a)

202,000

19,547,540

HealthStream, Inc. (a)

125,542

2,882,444

HMS Holdings Corp. (a)

101,300

2,553,773

 

32,963,711

Common Stocks - continued

Shares

Value

IT SERVICES - 1.0%

Data Processing & Outsourced Services - 1.0%

Maximus, Inc.

78,590

$ 6,262,837

LIFE SCIENCES TOOLS & SERVICES - 4.1%

Life Sciences Tools & Services - 4.1%

Agilent Technologies, Inc.

164,900

6,833,456

Bruker BioSciences Corp. (a)

98,800

1,755,676

Illumina, Inc. (a)(d)

257,940

16,686,139

 

25,275,271

PERSONAL PRODUCTS - 0.8%

Personal Products - 0.8%

Prestige Brands Holdings, Inc. (a)

171,172

4,613,085

PHARMACEUTICALS - 25.4%

Pharmaceuticals - 25.4%

AbbVie, Inc.

133,899

6,166,049

Actavis, Inc. (a)

116,095

12,274,724

Bayer AG (d)

58,300

6,082,368

Cadence Pharmaceuticals, Inc. (a)

149,019

1,055,055

Eli Lilly & Co.

29,045

1,608,512

Endo Health Solutions, Inc. (a)

254,769

9,334,736

Hi-Tech Pharmacal Co., Inc.

57,395

1,897,479

Impax Laboratories, Inc. (a)

98,800

1,729,000

Ipca Laboratories Ltd.

36,732

347,786

Meda AB (A Shares)

196,400

2,345,509

Merck & Co., Inc.

656,780

30,868,660

Mylan, Inc. (a)

173,782

5,058,794

Optimer Pharmaceuticals, Inc. (a)(d)

176,054

2,718,274

Pacira Pharmaceuticals, Inc. (a)

58,000

1,674,460

Pfizer, Inc.

541,998

15,755,882

Salix Pharmaceuticals Ltd. (a)

73,700

3,853,773

Sanofi SA

156,785

16,950,903

Shire PLC sponsored ADR

58,900

5,515,396

The Medicines Company (a)

70,900

2,393,584

UCB SA

56,200

3,321,685

Valeant Pharmaceuticals International, Inc. (Canada) (a)

164,704

12,506,681

ViroPharma, Inc. (a)

290,352

7,912,092

Warner Chilcott PLC

392,900

5,649,902

 

157,021,304

REAL ESTATE MANAGEMENT & DEVELOPMENT - 0.4%

Real Estate Development - 0.4%

PT Lippo Karawaci Tbk

17,745,500

2,464,014

TOTAL COMMON STOCKS

(Cost $462,226,869)


614,699,499

Convertible Preferred Stocks - 0.4%

Shares

Value

HEALTH CARE TECHNOLOGY - 0.4%

Health Care Technology - 0.4%

Castlight Health, Inc. Series D (a)(e)
(Cost $2,033,113)

336,800

$ 2,505,792

Money Market Funds - 4.1%

 

 

 

 

Fidelity Cash Central Fund, 0.13% (b)

1,290,207

1,290,207

Fidelity Securities Lending Cash Central Fund, 0.12% (b)(c)

24,395,049

24,395,049

TOTAL MONEY MARKET FUNDS

(Cost $25,685,256)


25,685,256

TOTAL INVESTMENT PORTFOLIO - 104.0%

(Cost $489,945,238)

642,890,547

NET OTHER ASSETS (LIABILITIES) - (4.0)%

(24,876,393 )

NET ASSETS - 100%

$ 618,014,154

Legend

(a) Non-income producing

(b) Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.

(c) Investment made with cash collateral received from securities on loan.

(d) Security or a portion of the security is on loan at period end.

(e) Restricted securities - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues). At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $2,505,792 or 0.4% of net assets.

Additional information on each restricted holding is as follows:

Security

Acquisition Date

Acquisition Cost

Castlight Health, Inc. Series D

4/25/12

$ 2,033,113

Affiliated Central Funds

Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:

Fund

Income earned

Fidelity Cash Central Fund

$ 11,697

Fidelity Securities Lending Cash Central Fund

92,135

Total

$ 103,832

Other Information

The following is a summary of the inputs used, as of April 30, 2013, involving the Fund's assets and liabilities carried at fair value. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. For more information on valuation inputs, and their aggregation into the levels used in the table below, please refer to the Investment Valuation section at the end of this listing.

Valuation Inputs at Reporting Date:

Description

Total

Level 1

Level 2

Level 3

Investments in Securities:

Common Stocks

$ 614,699,499

$ 597,748,596

$ 16,950,903

$ -

Convertible Preferred Stocks

2,505,792

-

-

2,505,792

Money Market Funds

25,685,256

25,685,256

-

-

Total Investments in Securities:

$ 642,890,547

$ 623,433,852

$ 16,950,903

$ 2,505,792

Income Tax Information

At April 30, 2013, the cost of investment securities for income tax purposes was $490,921,638. Net unrealized appreciation aggregated $151,968,909, of which $159,329,785 related to appreciated investment securities and $7,360,876 related to depreciated investment securities.

Investment Valuation

Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. In accordance with valuation policies and procedures approved by the Board of Trustees (the Board), the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Fidelity Management & Research Company (FMR) Fair Value Committee (the Committee), in accordance with procedures adopted by the Fund's Board. Factors used in determining fair value vary by investment type and may include market or investment specific events. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund's valuation policies and procedures and is responsible for approving and reporting to the Board all fair value determinations. The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels: Level 1 - quoted prices in active markets for identical investments: Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds etc.): Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available). Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the Fund's investments by major category are as follows:

Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy in these circumstances. Utilizing these techniques may result in transfers between Level 1 and Level 2. For restricted equity securities and private placements where observable inputs are limited, assumptions about market activity and risk are used and these securities are generally categorized as Level 3 in the hierarchy.

Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value each business day and are categorized as Level 1 in the hierarchy.

For additional information on the Fund's policy regarding valuation of investments and other significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.

Quarterly Report

The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please visit advisor.fidelity.com or call Fidelity at 1-877-208-0098 for a free copy of the fund's most recent prospectus and annual report.

Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.

Quarterly Report

Quarterly Holdings Report

for

Fidelity Advisor ® Financial Services Fund
Class A
Class T
Class B
Class C
Institutional Class


April 30, 2013

1.800326.109
AFFS-QTLY-0613

Investments April 30, 2013 (Unaudited)

Showing Percentage of Net Assets

Common Stocks - 96.5%

Shares

Value

CAPITAL MARKETS - 21.0%

Asset Management & Custody Banks - 11.7%

A.F.P. Provida SA sponsored ADR

25,100

$ 2,610,400

Affiliated Managers Group, Inc. (a)

114

17,748

AllianceBernstein Holding LP

5,700

135,033

Ameriprise Financial, Inc.

200

14,906

Apollo Global Management LLC Class A

69,174

1,862,164

Ares Capital Corp.

68,316

1,240,619

Ashmore Group PLC

60,332

374,117

Bank of New York Mellon Corp.

456

12,868

BlackRock, Inc. Class A

506

134,849

Carlyle Group LP

13,900

451,472

Franklin Resources, Inc.

105

16,239

Invesco Ltd.

10,838

343,998

Janus Capital Group, Inc.

90,075

803,469

Legg Mason, Inc.

853

27,177

Northern Trust Corp.

207

11,161

Och-Ziff Capital Management Group LLC Class A

19,500

200,070

State Street Corp.

300

17,541

The Blackstone Group LP

300,565

6,176,611

 

14,450,442

Diversified Capital Markets - 5.2%

Deutsche Bank AG

2,900

133,496

Deutsche Bank AG (NY Shares)

92,600

4,264,230

HFF, Inc.

8,500

178,075

UBS AG (NY Shares)

106,403

1,892,909

 

6,468,710

Investment Banking & Brokerage - 4.1%

Charles Schwab Corp.

900

15,264

Evercore Partners, Inc. Class A

50,822

1,918,531

GFI Group, Inc.

320,278

1,284,315

Goldman Sachs Group, Inc.

2,209

322,669

Investment Technology Group, Inc. (a)

1,125

12,251

Lazard Ltd. Class A

35,837

1,214,874

Macquarie Group Ltd.

393

15,967

Monex Group, Inc.

32

14,438

Morgan Stanley

11,545

255,722

 

5,054,031

TOTAL CAPITAL MARKETS

25,973,183

COMMERCIAL BANKS - 35.0%

Diversified Banks - 28.6%

Banco Bilbao Vizcaya Argentaria SA

93,300

908,235

Banco Bilbao Vizcaya Argentaria SA

2,248

21,819

Banco Bradesco SA (PN) sponsored ADR

753

12,492

Banco de Chile sponsored ADR

101

9,434

Banco Macro SA sponsored ADR (a)

900

14,346

Banco Santander Chile sponsored ADR

259

6,900

Banco Santander SA (Spain) sponsored ADR (d)

1,700

12,325

Banco Santander SA (Brasil) ADR

82,410

611,482

 

Shares

Value

BanColombia SA sponsored ADR

29,585

$ 2,004,975

Bangkok Bank PCL (For. Reg.)

15,900

122,974

Bank of Baroda

5,117

66,621

Bank of the Philippine Islands (BPI)

15,110

37,725

Barclays PLC sponsored ADR (d)

336,516

6,050,558

BBVA Banco Frances SA sponsored ADR (a)

2,300

10,327

BNP Paribas SA

113,313

6,313,818

China CITIC Bank Corp. Ltd. (H Shares)

25,000

14,078

Comerica, Inc.

271,545

9,843,502

CorpBanca SA sponsored ADR (d)

550

11,264

Credicorp Ltd. (NY Shares)

128

19,276

Credit Agricole SA (a)

200

1,831

Criteria CaixaCorp SA (d)

29,274

108,371

Development Credit Bank Ltd. (a)

27,538

24,083

Grupo Financiero Banorte S.A.B. de CV Series O

53,300

401,913

Grupo Financiero Galicia SA sponsored ADR (a)(d)

1,800

10,134

Guaranty Trust Bank PLC GDR (Reg. S)

3,700

30,340

Hana Financial Group, Inc.

2,410

77,007

HDFC Bank Ltd. sponsored ADR

3,200

135,808

Hong Leong Bank Bhd

3,400

16,159

HSBC Holdings PLC sponsored ADR

200

10,972

ICICI Bank Ltd. sponsored ADR

31,823

1,489,953

Industrial & Commercial Bank of China Ltd. (H Shares)

6,000

4,222

Intesa Sanpaolo SpA

8,305

15,061

Itau Unibanco Holding SA sponsored ADR

619

10,418

KB Financial Group, Inc.

2,210

72,252

Malayan Banking Bhd

26,557

83,970

National Bank of Greece SA sponosored ADR (a)

138,700

124,969

Nordea Bank AB

1,200

14,377

PT Bank Bukopin Tbk

3,467,500

328,115

PT Bank Central Asia Tbk

13,500

14,927

Raiffeisen International Bank-Holding AG

900

31,759

Royal Bank of Scotland Group PLC (a)

29,232

139,490

Sberbank (Savings Bank of the Russian Federation) sponsored ADR

1,100

14,146

Societe Generale Series A

79,400

2,883,926

Standard Chartered PLC (United Kingdom)

491

12,333

Swedbank AB (A Shares)

900

22,149

The Jammu & Kashmir Bank Ltd.

4,314

109,503

The Toronto-Dominion Bank

126

10,329

U.S. Bancorp

91,772

3,054,172

United Overseas Bank Ltd.

1,000

17,334

Wells Fargo & Co.

348

13,217

Yes Bank Ltd.

1,839

17,614

 

35,393,005

Regional Banks - 6.4%

Alerus Financial Corp.

435

15,116

Common Stocks - continued

Shares

Value

COMMERCIAL BANKS - CONTINUED

Regional Banks - continued

Bancorp New Jersey, Inc.

100

$ 1,270

BancorpSouth, Inc.

4,900

78,400

Bank of the Ozarks, Inc.

6,516

266,700

BankUnited, Inc.

500

12,675

BB&T Corp.

405

12,462

Boston Private Financial Holdings, Inc.

2,200

21,208

Bridge Capital Holdings (a)

48,490

706,984

Canadian Western Bank, Edmonton

400

11,300

Cascade Bancorp (a)

900

5,373

Citizens & Northern Corp.

520

10,067

City Holding Co.

500

19,090

City National Corp.

300

17,169

CNB Financial Corp., Pennsylvania

803

13,001

CoBiz, Inc.

128,200

1,097,392

Commerce Bancshares, Inc.

5,200

208,572

Fifth Third Bancorp

16,740

285,082

First Business Finance Services, Inc.

500

13,760

First Commonwealth Financial Corp.

15,322

109,552

First Interstate Bancsystem, Inc.

31,582

641,746

First Midwest Bancorp, Inc., Delaware

1,200

15,060

First Republic Bank

2,681

101,824

FirstMerit Corp.

800

13,704

FNB Corp., Pennsylvania

1,100

12,529

Glacier Bancorp, Inc.

924

17,048

Huntington Bancshares, Inc.

16,368

117,359

NBT Bancorp, Inc.

200

4,050

Northrim Bancorp, Inc.

1,469

31,995

Pacific Continental Corp.

19,828

221,677

PNC Financial Services Group, Inc.

12,609

855,899

PrivateBancorp, Inc.

900

17,262

PT Bank Tabungan Negara Tbk

1,052,000

161,222

Regions Financial Corp.

175,836

1,492,848

Sandy Spring Bancorp, Inc.

200

4,096

SCBT Financial Corp.

500

23,885

Spar Nord Bank A/S (a)

500

3,215

SunTrust Banks, Inc.

10,600

310,050

Susquehanna Bancshares, Inc.

33,214

387,607

SVB Financial Group (a)

312

22,186

Texas Capital Bancshares, Inc. (a)

200

8,332

Trustmark Corp.

2,575

63,216

UMB Financial Corp.

1,200

60,408

Valley National Bancorp (d)

1,053

9,466

Virginia Commerce Bancorp, Inc. (a)

2,000

26,880

Washington Trust Bancorp, Inc.

5,644

150,977

Webster Financial Corp.

4,400

102,828

Westamerica Bancorp.

100

4,339

 

Shares

Value

Western Alliance Bancorp. (a)

852

$ 12,533

Zions Bancorporation

5,000

123,100

 

7,922,514

TOTAL COMMERCIAL BANKS

43,315,519

COMMERCIAL SERVICES & SUPPLIES - 0.0%

Diversified Support Services - 0.0%

Intrum Justitia AB

1,000

20,599

CONSTRUCTION MATERIALS - 0.1%

Construction Materials - 0.1%

Headwaters, Inc. (a)

4,700

51,042

CONSUMER FINANCE - 2.6%

Consumer Finance - 2.6%

American Express Co.

223

15,255

Capital One Financial Corp.

32,102

1,854,854

DFC Global Corp. (a)

2,000

27,000

Discover Financial Services

14,000

612,360

EZCORP, Inc. (non-vtg.) Class A (a)

14,666

247,855

First Cash Financial Services, Inc. (a)

3,390

174,483

Green Dot Corp. Class A (a)

1,900

29,849

International Personal Finance PLC

176

1,394

Nelnet, Inc. Class A

700

23,800

Netspend Holdings, Inc. (a)

1,331

21,243

PT Clipan Finance Indonesia Tbk

338,000

15,470

Regional Management Corp. (a)

9,500

205,960

SLM Corp.

665

13,732

 

3,243,255

DIVERSIFIED CONSUMER SERVICES - 0.0%

Specialized Consumer Services - 0.0%

Sotheby's Class A (Ltd. vtg.)

350

12,418

DIVERSIFIED FINANCIAL SERVICES - 16.0%

Other Diversified Financial Services - 13.8%

Bank of America Corp.

498,056

6,131,069

BTG Pactual Participations Ltd. unit

14,485

238,696

Challenger Ltd.

71,751

312,414

Citigroup, Inc.

137,165

6,400,119

JPMorgan Chase & Co.

81,185

3,978,877

 

17,061,175

Specialized Finance - 2.2%

BM&F Bovespa SA

1,900

13,191

CBOE Holdings, Inc.

52,575

1,973,140

CME Group, Inc.

184

11,198

IntercontinentalExchange, Inc. (a)

84

13,686

MarketAxess Holdings, Inc.

900

38,088

McGraw-Hill Companies, Inc.

11,600

627,676

Moody's Corp.

231

14,056

NYSE Euronext

300

11,643

Common Stocks - continued

Shares

Value

DIVERSIFIED FINANCIAL SERVICES - CONTINUED

Specialized Finance - continued

PHH Corp. (a)

522

$ 11,004

The NASDAQ Stock Market, Inc.

361

10,642

 

2,724,324

TOTAL DIVERSIFIED FINANCIAL SERVICES

19,785,499

ENERGY EQUIPMENT & SERVICES - 0.0%

Oil & Gas Equipment & Services - 0.0%

SBM Offshore NV (a)

1,200

19,312

HOTELS, RESTAURANTS & LEISURE - 0.0%

Casinos & Gaming - 0.0%

Las Vegas Sands Corp.

227

12,769

MGM Mirage, Inc. (a)

915

12,920

Wynn Resorts Ltd.

71

9,748

 

35,437

Hotels, Resorts & Cruise Lines - 0.0%

Starwood Hotels & Resorts Worldwide, Inc.

200

12,904

TOTAL HOTELS, RESTAURANTS & LEISURE

48,341

HOUSEHOLD DURABLES - 0.0%

Homebuilding - 0.0%

M.D.C. Holdings, Inc.

400

15,040

PulteGroup, Inc. (a)

1,400

29,386

 

44,426

INDUSTRIAL CONGLOMERATES - 0.0%

Industrial Conglomerates - 0.0%

Keppel Corp. Ltd.

1,000

8,695

INSURANCE - 4.1%

Insurance Brokers - 0.4%

Aon PLC

300

18,105

Brasil Insurance Participacoes e Administracao SA

23,000

244,053

Marsh & McLennan Companies, Inc.

6,300

239,463

 

501,621

Life & Health Insurance - 0.9%

AFLAC, Inc.

204

11,106

AIA Group Ltd.

49,800

221,079

Citizens, Inc. Class A (a)

2,100

13,734

Delta Lloyd NV

831

15,923

FBL Financial Group, Inc. Class A

200

7,862

Lincoln National Corp.

400

13,604

MetLife, Inc.

16,226

632,652

Phoenix Companies, Inc. (a)

285

8,296

Ping An Insurance (Group) Co. of China Ltd. (H Shares)

3,000

23,756

Prudential Financial, Inc.

157

9,486

Resolution Ltd.

2,800

11,478

 

Shares

Value

StanCorp Financial Group, Inc.

300

$ 12,954

Symetra Financial Corp.

1,100

14,993

Torchmark Corp.

300

18,621

Unum Group

600

16,734

 

1,032,278

Multi-Line Insurance - 0.6%

American International Group, Inc. (a)

330

13,669

Assurant, Inc.

8,329

395,961

Fairfax Financial Holdings Ltd. (sub. vtg.)

100

40,116

Genworth Financial, Inc. Class A (a)

1,850

18,556

Hartford Financial Services Group, Inc.

3,600

101,124

Loews Corp.

1,900

84,873

Porto Seguro SA

8,100

100,483

 

754,782

Property & Casualty Insurance - 1.7%

ACE Ltd.

6,549

583,778

Allied World Assurance Co. Holdings Ltd.

2,000

181,620

Allstate Corp.

300

14,778

Arch Capital Group Ltd. (a)

8,300

440,398

Axis Capital Holdings Ltd.

5,400

241,002

Berkshire Hathaway, Inc. Class B (a)

149

15,842

CNA Financial Corp.

3,118

105,108

Erie Indemnity Co. Class A

363

28,884

Fidelity National Financial, Inc. Class A

418

11,223

Hanover Insurance Group, Inc.

1,700

85,731

The Travelers Companies, Inc.

192

16,399

W.R. Berkley Corp.

2,500

108,550

XL Group PLC Class A

10,044

312,770

 

2,146,083

Reinsurance - 0.5%

Everest Re Group Ltd.

100

13,499

Montpelier Re Holdings Ltd.

4,000

103,040

Platinum Underwriters Holdings Ltd.

3,400

192,950

RenaissanceRe Holdings Ltd.

133

12,487

Swiss Re Ltd.

162

12,884

Validus Holdings Ltd.

8,000

308,880

 

643,740

TOTAL INSURANCE

5,078,504

INTERNET SOFTWARE & SERVICES - 0.0%

Internet Software & Services - 0.0%

eBay, Inc. (a)

309

16,189

IT SERVICES - 5.3%

Data Processing & Outsourced Services - 5.0%

Alliance Data Systems Corp. (a)

43

7,386

Cielo SA

456

12,027

Fidelity National Information Services, Inc.

600

25,230

Fiserv, Inc. (a)

233

21,229

Global Cash Access Holdings, Inc. (a)

9,300

66,309

Common Stocks - continued

Shares

Value

IT SERVICES - CONTINUED

Data Processing & Outsourced Services - continued

Global Payments, Inc.

40,055

$ 1,858,552

Jack Henry & Associates, Inc.

2,810

130,384

Lender Processing Services, Inc.

100

2,774

Total System Services, Inc.

24,566

580,249

Vantiv, Inc. (a)

26,400

594,792

VeriFone Systems, Inc. (a)

133,441

2,866,313

Visa, Inc. Class A

100

16,846

 

6,182,091

IT Consulting & Other Services - 0.3%

Accenture PLC Class A

200

16,288

Cognizant Technology Solutions Corp. Class A (a)

4,949

320,695

 

336,983

TOTAL IT SERVICES

6,519,074

MACHINERY - 0.1%

Industrial Machinery - 0.1%

Middleby Corp. (a)

500

74,790

PROFESSIONAL SERVICES - 0.0%

Research & Consulting Services - 0.0%

Equifax, Inc.

370

22,644

IHS, Inc. Class A (a)

75

7,307

 

29,951

REAL ESTATE INVESTMENT TRUSTS - 10.9%

Diversified REITs - 0.6%

American Assets Trust, Inc.

4,100

138,416

Duke Realty LP

15,800

278,712

First Potomac Realty Trust

700

11,200

Lexington Corporate Properties Trust

26,201

335,635

Vornado Realty Trust

200

17,512

 

781,475

Industrial REITs - 0.0%

DCT Industrial Trust, Inc.

400

3,132

Prologis, Inc.

294

12,333

Stag Industrial, Inc.

1,100

24,244

 

39,709

Mortgage REITs - 0.9%

American Capital Agency Corp.

22,450

747,810

American Capital Mortgage Investment Corp.

1,200

31,872

Invesco Mortgage Capital, Inc.

600

12,840

PennyMac Mortgage Investment Trust

700

17,675

Two Harbors Investment Corp.

23,300

279,134

 

1,089,331

Office REITs - 1.6%

BioMed Realty Trust, Inc.

5,700

128,307

Boston Properties, Inc.

134

14,664

 

Shares

Value

Corporate Office Properties Trust (SBI)

3,900

$ 113,061

CyrusOne, Inc.

10,100

242,299

Douglas Emmett, Inc.

29,112

761,861

Highwoods Properties, Inc. (SBI)

13,080

536,672

K-REIT Asia

200

245

Kilroy Realty Corp.

2,800

158,452

MPG Office Trust, Inc. (a)

5,300

16,536

SL Green Realty Corp.

100

9,070

 

1,981,167

Residential REITs - 1.3%

American Campus Communities, Inc.

6,049

270,027

Apartment Investment & Management Co. Class A

4,641

144,382

BRE Properties, Inc.

500

25,240

Camden Property Trust (SBI)

7,350

531,699

Campus Crest Communities, Inc.

1,100

15,026

Colonial Properties Trust (SBI)

5,300

123,013

Equity Residential (SBI)

200

11,612

Home Properties, Inc.

5,800

373,868

Silver Bay Realty Trust Corp. (d)

1,137

21,694

UDR, Inc.

548

13,470

 

1,530,031

Retail REITs - 0.4%

Federal Realty Investment Trust (SBI)

103

12,052

Glimcher Realty Trust

400

5,016

Kimco Realty Corp.

700

16,646

Realty Income Corp.

8,050

410,309

Simon Property Group, Inc.

38

6,767

Urstadt Biddle Properties, Inc. Class A

1,300

28,951

 

479,741

Specialized REITs - 6.1%

American Tower Corp.

100

8,399

Big Yellow Group PLC

795,776

4,987,739

CubeSmart

1,000

17,570

DiamondRock Hospitality Co.

9,400

93,812

HCP, Inc.

2,217

118,166

Health Care REIT, Inc.

280

20,992

Host Hotels & Resorts, Inc.

1,600

29,232

National Health Investors, Inc.

3,900

258,336

Plum Creek Timber Co., Inc.

600

30,924

Potlatch Corp.

3,900

184,665

Public Storage

105

17,325

Rayonier, Inc.

6,300

374,346

Sovran Self Storage, Inc.

400

27,440

Strategic Hotel & Resorts, Inc. (a)

139,684

1,127,250

Sunstone Hotel Investors, Inc. (a)

13,600

168,776

Ventas, Inc.

195

15,528

Weyerhaeuser Co.

3,500

106,785

 

7,587,285

TOTAL REAL ESTATE INVESTMENT TRUSTS

13,488,739

Common Stocks - continued

Shares

Value

REAL ESTATE MANAGEMENT & DEVELOPMENT - 1.3%

Diversified Real Estate Activities - 1.1%

Countrywide PLC

2,100

$ 15,193

Tejon Ranch Co. (a)

5,564

162,358

The St. Joe Co. (a)(d)

61,471

1,202,987

 

1,380,538

Real Estate Development - 0.0%

Bukit Sembawang Estates Ltd.

4,000

23,155

Real Estate Operating Companies - 0.1%

BR Malls Participacoes SA

700

8,257

Castellum AB

927

13,874

Forest City Enterprises, Inc. Class A (a)

6,300

117,621

Thomas Properties Group, Inc.

2,262

11,514

 

151,266

Real Estate Services - 0.1%

CBRE Group, Inc. (a)

487

11,795

Jones Lang LaSalle, Inc.

116

11,486

Kennedy-Wilson Holdings, Inc.

2,000

33,260

 

56,541

TOTAL REAL ESTATE MANAGEMENT & DEVELOPMENT

1,611,500

SOFTWARE - 0.0%

Application Software - 0.0%

EPIQ Systems, Inc.

500

6,985

Fair Isaac Corp.

100

4,658

 

11,643

SPECIALTY RETAIL - 0.0%

Home Improvement Retail - 0.0%

Home Depot, Inc.

300

22,005

THRIFTS & MORTGAGE FINANCE - 0.1%

Thrifts & Mortgage Finance - 0.1%

Brookline Bancorp, Inc., Delaware

800

6,720

Cape Bancorp, Inc.

1,400

12,614

Cheviot Financial Corp.

4,910

56,416

Eagle Bancorp Montana, Inc.

300

3,228

Fannie Mae (a)

9,700

8,022

Hudson City Bancorp, Inc.

800

6,648

People's United Financial, Inc.

1,100

14,476

 

108,124

TOTAL COMMON STOCKS

(Cost $109,854,801)


119,482,808

Nonconvertible Preferred Stocks - 0.3%

Shares

Value

COMMERCIAL BANKS - 0.3%

Diversified Banks - 0.1%

Banco ABC Brasil SA

7,685

$ 60,381

Banco Pine SA

17,128

118,481

 

178,862

Regional Banks - 0.2%

Banco Daycoval SA (PN)

11,300

59,416

Texas Capital Bancshares, Inc. 6.50%

5,500

140,140

 

199,556

TOTAL COMMERCIAL BANKS

378,418

TOTAL NONCONVERTIBLE PREFERRED STOCKS

(Cost $366,193)


378,418

Money Market Funds - 4.9%

 

 

 

 

Fidelity Cash Central Fund, 0.13% (b)

5,667,409

5,667,409

Fidelity Securities Lending Cash Central Fund, 0.12% (b)(c)

409,808

409,808

TOTAL MONEY MARKET FUNDS

(Cost $6,077,217)


6,077,217

TOTAL INVESTMENT PORTFOLIO - 101.7%

(Cost $116,298,211)

125,938,443

NET OTHER ASSETS (LIABILITIES) - (1.7)%

(2,049,351 )

NET ASSETS - 100%

$ 123,889,092

Legend

(a) Non-income producing

(b) Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.

(c) Investment made with cash collateral received from securities on loan.

(d) Security or a portion of the security is on loan at period end.

Affiliated Central Funds

Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:

Fund

Income earned

Fidelity Cash Central Fund

$ 3,440

Fidelity Securities Lending Cash Central Fund

8,439

Total

$ 11,879

Other Information

The following is a summary of the inputs used, as of April 30, 2013, involving the Fund's assets and liabilities carried at fair value. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. For more information on valuation inputs, and their aggregation into the levels used in the table below, please refer to the Investment Valuation section at the end of this listing.

Valuation Inputs at Reporting Date:

Description

Total

Level 1

Level 2

Level 3

Investments in Securities:

Common Stocks

$ 119,482,808

$ 118,197,283

$ 1,285,525

$ -

Nonconvertible Preferred Stocks

378,418

378,418

-

-

Money Market Funds

6,077,217

6,077,217

-

-

Total Investments in Securities:

$ 125,938,443

$ 124,652,918

$ 1,285,525

$ -

Income Tax Information

At April 30, 2013, the cost of investment securities for income tax purposes was $117,850,468. Net unrealized appreciation aggregated $8,087,975, of which $11,350,868 related to appreciated investment securities and $3,262,893 related to depreciated investment securities.

Investment Valuation

Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. In accordance with valuation policies and procedures approved by the Board of Trustees (the Board), the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Fidelity Management & Research Company (FMR) Fair Value Committee (the Committee), in accordance with procedures adopted by the Fund's Board. Factors used in determining fair value vary by investment type and may include market or investment specific events. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund's valuation policies and procedures and is responsible for approving and reporting to the Board all fair value determinations. The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels: Level 1 - quoted prices in active markets for identical investments: Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds etc.): Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available). Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the Fund's investments by major category are as follows:

Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy in these circumstances. Utilizing these techniques may result in transfers between Level 1 and Level 2.

Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value each business day and are categorized as Level 1 in the hierarchy.

For additional information on the Fund's policy regarding valuation of investments and other significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.

Quarterly Report

The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please visit advisor.fidelity.com or call Fidelity at 1-877-208-0098 for a free copy of the fund's most recent prospectus and annual report.

Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.

Quarterly Report

Quarterly Holdings Report

for

Fidelity Advisor ® Technology Fund
Class A
Class T
Class B
Class C
Institutional Class


April 30, 2013

1.800330.109
AFTF-QTLY-0613

Investments April 30, 2013 (Unaudited)

Showing Percentage of Net Assets

Common Stocks - 98.5%

Shares

Value

AEROSPACE & DEFENSE - 0.0%

Aerospace & Defense - 0.0%

DigitalGlobe, Inc. (a)

236

$ 6,889

AUTOMOBILES - 0.1%

Automobile Manufacturers - 0.1%

Tesla Motors, Inc. (a)

12,300

664,077

CHEMICALS - 0.2%

Specialty Chemicals - 0.2%

JSR Corp.

13,100

301,563

Nitto Denko Corp.

17,000

1,116,892

 

1,418,455

COMMUNICATIONS EQUIPMENT - 14.3%

Communications Equipment - 14.3%

AAC Acoustic Technology Holdings, Inc.

16,500

80,478

ADTRAN, Inc.

30,586

642,306

ADVA AG Optical Networking (a)

92,560

444,802

Alcatel-Lucent SA (a)(d)

535,653

737,731

Alcatel-Lucent SA sponsored ADR (a)

526,688

721,563

Aruba Networks, Inc. (a)(d)

118,242

2,659,263

Brocade Communications Systems, Inc. (a)

71,400

415,548

Ciena Corp. (a)

168,562

2,521,688

Cisco Systems, Inc.

552,300

11,554,116

Comba Telecom Systems Holdings Ltd.

66,000

22,538

F5 Networks, Inc. (a)

241,960

18,493,003

Finisar Corp. (a)

338,501

4,346,353

HTC Corp.

10,000

102,069

Infinera Corp. (a)

330,885

2,786,052

JDS Uniphase Corp. (a)

83,615

1,128,803

Juniper Networks, Inc. (a)

1,184,655

19,606,040

Motorola Solutions, Inc.

1,318

75,390

Palo Alto Networks, Inc.

7,532

407,481

Polycom, Inc. (a)

119

1,250

QUALCOMM, Inc.

489,314

30,151,529

Radware Ltd. (a)

78,548

1,177,435

Research In Motion Ltd. (a)

300

4,887

Riverbed Technology, Inc. (a)

470

6,984

Sandvine Corp. (U.K.) (a)

1,305,800

2,657,095

SerComm Corp.

273,000

378,627

Sonus Networks, Inc. (a)

1,950,454

4,095,953

Spirent Communications PLC

115,600

234,335

Telefonaktiebolaget LM Ericsson:

(B Shares)

31,000

385,528

(B Shares) sponsored ADR

181,347

2,232,382

ZTE Corp. (H Shares)

220,800

372,166

 

108,443,395

COMPUTERS & PERIPHERALS - 14.3%

Computer Hardware - 11.1%

3D Systems Corp. (a)(d)

24,038

919,213

Advantech Co. Ltd.

674,000

3,222,584

Apple, Inc.

151,615

67,127,541

 

Shares

Value

Hewlett-Packard Co.

590

$ 12,154

Lenovo Group Ltd.

9,872,000

9,019,475

Quanta Computer, Inc.

41,000

84,808

Stratasys Ltd. (a)

16,335

1,356,622

Toshiba Corp.

414,000

2,282,868

Wistron Corp.

81,200

82,467

 

84,107,732

Computer Storage & Peripherals - 3.2%

ADLINK Technology, Inc.

2,300

2,480

Catcher Technology Co. Ltd.

402,000

2,037,945

Chicony Electronics Co. Ltd.

723,000

2,123,154

EMC Corp. (a)

413,983

9,285,639

Fusion-io, Inc. (a)

54,800

1,029,144

Gemalto NV

940

76,801

NetApp, Inc. (a)

2,395

83,562

SanDisk Corp. (a)

177,199

9,292,316

Synaptics, Inc. (a)

181

7,463

Wacom Co. Ltd.

160

733,343

 

24,671,847

TOTAL COMPUTERS & PERIPHERALS

108,779,579

DIVERSIFIED CONSUMER SERVICES - 0.0%

Education Services - 0.0%

Educomp Solutions Ltd.

16,123

19,341

New Oriental Education & Technology Group, Inc. sponsored ADR

3,974

76,023

 

95,364

ELECTRICAL EQUIPMENT - 0.1%

Electrical Components & Equipment - 0.1%

Dynapack International Technology Corp.

14,000

48,661

TECO Electric & Machinery Co. Ltd.

471,000

443,210

 

491,871

ELECTRONIC EQUIPMENT & COMPONENTS - 4.5%

Electronic Components - 1.5%

Aeroflex Holding Corp. (a)

13,464

100,172

Amphenol Corp. Class A

29,208

2,205,788

AU Optronics Corp. (a)

9,000

4,245

Delta Electronics, Inc.

186,000

892,472

InvenSense, Inc. (a)

123,737

1,153,229

Ledlink Optics, Inc.

379,000

1,130,960

Omron Corp.

33,300

1,051,943

Tong Hsing Electronics Industries Ltd.

585,000

2,578,840

TXC Corp.

253,000

394,642

Universal Display Corp. (a)(d)

36,492

1,147,308

Yaskawa Electric Corp.

73,000

893,206

 

11,552,805

Electronic Equipment & Instruments - 0.9%

Chroma ATE, Inc.

358,683

769,910

FEI Co.

3,300

210,804

Hitachi High-Technologies Corp.

8,000

199,850

Common Stocks - continued

Shares

Value

ELECTRONIC EQUIPMENT & COMPONENTS - CONTINUED

Electronic Equipment & Instruments - continued

Keyence Corp.

6,050

$ 1,919,944

National Instruments Corp.

74,993

2,049,559

RealD, Inc. (a)(d)

12,949

193,847

Test Research, Inc.

19,214

31,730

TPK Holding Co. Ltd.

23,000

467,175

TPK Holding Co. Ltd. GDR (Reg. S)

51,469

1,045,437

 

6,888,256

Electronic Manufacturing Services - 1.3%

Benchmark Electronics, Inc. (a)

1,200

21,408

Fabrinet (a)

6,300

86,499

IPG Photonics Corp. (d)

2,200

140,096

Jabil Circuit, Inc.

66,537

1,184,359

Ju Teng International Holdings Ltd.

1,292,000

840,783

KEMET Corp. (a)

1,417

8,828

TE Connectivity Ltd.

112,985

4,920,497

Trimble Navigation Ltd. (a)

79,097

2,273,248

 

9,475,718

Technology Distributors - 0.8%

Arrow Electronics, Inc. (a)

53

2,079

Digital China Holdings Ltd. (H Shares)

3,843,000

4,843,275

Redington India Ltd.

57,478

84,528

VST Holdings Ltd.

980,000

262,675

WPG Holding Co. Ltd.

686,975

828,144

WT Microelectronics Co. Ltd.

17,509

20,899

 

6,041,600

TOTAL ELECTRONIC EQUIPMENT & COMPONENTS

33,958,379

HEALTH CARE EQUIPMENT & SUPPLIES - 0.1%

Health Care Equipment - 0.1%

Biosensors International Group Ltd. (a)

835,000

813,510

HEALTH CARE TECHNOLOGY - 0.7%

Health Care Technology - 0.7%

athenahealth, Inc. (a)

7,866

757,181

Cerner Corp. (a)

24,677

2,387,993

So-net M3, Inc.

791

1,789,096

 

4,934,270

HOUSEHOLD DURABLES - 0.6%

Consumer Electronics - 0.6%

Alpine Electronics, Inc.

208,000

2,122,958

Sony Corp. sponsored ADR (d)

133,400

2,191,762

 

4,314,720

Household Appliances - 0.0%

Haier Electronics Group Co. Ltd.

17,000

30,363

TOTAL HOUSEHOLD DURABLES

4,345,083

 

Shares

Value

HOUSEHOLD PRODUCTS - 0.0%

Household Products - 0.0%

NVC Lighting Holdings Ltd.

180,000

$ 44,071

INDUSTRIAL CONGLOMERATES - 0.0%

Industrial Conglomerates - 0.0%

Samsung Techwin Co. Ltd.

196

12,188

INTERNET & CATALOG RETAIL - 0.6%

Internet Retail - 0.6%

Amazon.com, Inc. (a)

7,102

1,802,559

E-Commerce China Dangdang, Inc. ADR (a)

260

998

Expedia, Inc.

29

1,619

Groupon, Inc. Class A (a)(d)

134,300

819,230

Netflix, Inc. (a)

2,300

496,961

priceline.com, Inc. (a)

569

396,018

Rakuten, Inc.

41,400

441,587

Start Today Co. Ltd.

48,200

729,778

TripAdvisor, Inc. (a)

2,394

125,877

 

4,814,627

INTERNET SOFTWARE & SERVICES - 17.8%

Internet Software & Services - 17.8%

Active Network, Inc. (a)

64,340

323,630

Akamai Technologies, Inc. (a)

1,994

87,557

Angie's List, Inc. (a)

74,139

1,797,129

Baidu.com, Inc. sponsored ADR (a)

51

4,378

Bankrate, Inc. (a)

26,500

357,220

Bazaarvoice, Inc. (a)

2,800

20,300

Cornerstone OnDemand, Inc. (a)

101,457

3,680,860

DealerTrack Holdings, Inc. (a)

31,770

884,795

Demandware, Inc. (a)

49,714

1,357,192

E2open, Inc.

37,900

538,559

eBay, Inc. (a)

321,900

16,864,341

ExactTarget, Inc. (a)

129,500

2,535,610

Facebook, Inc. Class A

14,258

395,802

Google, Inc. Class A (a)

84,791

69,916,111

INFO Edge India Ltd.

35,836

235,402

IntraLinks Holdings, Inc. (a)

127,914

731,668

Kakaku.com, Inc.

16,600

429,142

Keynote Systems, Inc.

26,095

292,525

LinkedIn Corp. (a)

49,940

9,592,975

LogMeIn, Inc. (a)

6,996

157,970

Mail.Ru Group Ltd. GDR (e)

1,800

48,600

MercadoLibre, Inc.

134

13,479

Millennial Media, Inc. (a)

141,724

982,147

NHN Corp.

286

76,848

Open Text Corp.

100

6,534

PChome Online, Inc.

79,000

357,630

Qihoo 360 Technology Co. Ltd. ADR (a)

300

10,290

Rackspace Hosting, Inc. (a)

7,204

347,233

Renren, Inc. ADR (a)

5,900

16,520

Responsys, Inc. (a)

248,552

1,931,249

Common Stocks - continued

Shares

Value

INTERNET SOFTWARE & SERVICES - CONTINUED

Internet Software & Services - continued

SciQuest, Inc. (a)

95,327

$ 2,179,175

SINA Corp. (a)

56,489

3,181,460

SouFun Holdings Ltd. ADR

157

4,018

Tencent Holdings Ltd.

144,600

4,960,280

Velti PLC (a)

10,736

21,472

VeriSign, Inc. (a)

8,430

388,370

Vocus, Inc. (a)

117,715

989,983

Web.com Group, Inc. (a)

500

8,700

XO Group, Inc. (a)

5,200

58,552

Yahoo!, Inc. (a)

354,411

8,764,584

Yandex NV (a)

16,576

426,666

YouKu.com, Inc. ADR (a)

404

8,185

 

134,985,141

IT SERVICES - 10.7%

Data Processing & Outsourced Services - 9.3%

Automatic Data Processing, Inc.

1,366

91,986

EVERTEC, Inc.

10,100

202,505

Fidelity National Information Services, Inc.

301,254

12,667,731

Fiserv, Inc. (a)

21,412

1,950,847

FleetCor Technologies, Inc. (a)

10,106

777,151

Global Payments, Inc.

97,600

4,528,640

Jack Henry & Associates, Inc.

20,492

950,829

MasterCard, Inc. Class A

28,485

15,750,211

Paychex, Inc.

54,004

1,966,286

Syntel, Inc.

1,100

69,487

The Western Union Co.

127,648

1,890,467

Total System Services, Inc.

182,055

4,300,139

VeriFone Systems, Inc. (a)

44

945

Visa, Inc. Class A

149,174

25,129,852

 

70,277,076

IT Consulting & Other Services - 1.4%

Accenture PLC Class A

55,674

4,534,091

Bit-isle, Inc.

1,600

22,841

Camelot Information Systems, Inc. ADR (a)

145

251

ChinaSoft International Ltd. (a)

20,000

4,948

Cognizant Technology Solutions Corp. Class A (a)

53,438

3,462,782

EPAM Systems, Inc. (a)

44,400

954,600

IBM Corp.

375

75,953

InterXion Holding N.V. (a)

10,000

250,300

Pactera Technology International Ltd. ADR

94,096

478,949

ServiceSource International, Inc. (a)

82,288

526,643

Teradata Corp. (a)

1,246

63,633

Virtusa Corp. (a)

16,100

357,581

 

10,732,572

TOTAL IT SERVICES

81,009,648

 

Shares

Value

LEISURE EQUIPMENT & PRODUCTS - 0.1%

Photographic Products - 0.1%

Sunny Optical Technology Group Co. Ltd.

401,000

$ 532,245

LIFE SCIENCES TOOLS & SERVICES - 0.1%

Life Sciences Tools & Services - 0.1%

Illumina, Inc. (a)(d)

1,406

90,954

WuXi PharmaTech Cayman, Inc. sponsored ADR (a)

27,300

520,611

 

611,565

MACHINERY - 0.4%

Industrial Machinery - 0.4%

Airtac International Group

74,000

392,709

Fanuc Corp.

12,200

1,841,616

Mirle Automation Corp.

95,738

66,390

Nippon Thompson Co. Ltd.

33,000

164,757

Shin Zu Shing Co. Ltd.

154,000

394,269

 

2,859,741

MEDIA - 0.3%

Advertising - 0.2%

Dentsu, Inc.

200

6,953

Focus Media Holding Ltd. ADR

45,341

1,236,449

ReachLocal, Inc. (a)

1,558

25,972

 

1,269,374

Cable & Satellite - 0.0%

DIRECTV (a)

190

10,746

Movies & Entertainment - 0.1%

IMAX Corp. (a)

29,830

761,560

TOTAL MEDIA

2,041,680

OFFICE ELECTRONICS - 0.0%

Office Electronics - 0.0%

Xerox Corp.

8,333

71,497

PHARMACEUTICALS - 0.1%

Pharmaceuticals - 0.1%

China Medical System Holdings Ltd.

1,099,250

1,077,981

PROFESSIONAL SERVICES - 0.0%

Research & Consulting Services - 0.0%

Acacia Research Corp.

8,600

204,852

IHS, Inc. Class A (a)

850

82,816

 

287,668

REAL ESTATE INVESTMENT TRUSTS - 0.3%

Specialized REITs - 0.3%

American Tower Corp.

23,979

2,013,996

SEMICONDUCTORS & SEMICONDUCTOR EQUIPMENT - 10.8%

Semiconductor Equipment - 1.3%

Advanced Energy Industries, Inc. (a)

5,757

97,754

Aixtron AG

44,100

632,166

Common Stocks - continued

Shares

Value

SEMICONDUCTORS & SEMICONDUCTOR EQUIPMENT - CONTINUED

Semiconductor Equipment - continued

Aixtron AG sponsored ADR (d)

11,900

$ 170,884

Amkor Technology, Inc. (a)(d)

1,594

6,743

Applied Materials, Inc.

5,944

86,247

ASM International NV (depositary receipt)

2,330

78,008

ASML Holding NV (d)

1,206

89,690

Dainippon Screen Manufacturing Co. Ltd.

87,000

448,731

Entegris, Inc. (a)

79,708

755,632

GCL-Poly Energy Holdings Ltd.

4,354,000

880,882

GT Advanced Technologies, Inc. (a)(d)

125,574

493,506

ICD Co. Ltd. (a)

5,573

71,078

Lam Research Corp. (a)

1,989

91,932

Rubicon Technology, Inc. (a)(d)

143,652

1,064,461

Teradyne, Inc. (a)

4,232

69,574

Tessera Technologies, Inc.

134,614

2,742,087

Ultratech, Inc. (a)

69,227

2,040,120

Veeco Instruments, Inc. (a)(d)

11,800

449,226

 

10,268,721

Semiconductors - 9.5%

Advanced Micro Devices, Inc. (a)(d)

1,157

3,263

Alpha & Omega Semiconductor Ltd. (a)

8,432

61,048

Altera Corp.

420,576

13,462,638

Analog Devices, Inc.

8,958

394,062

Applied Micro Circuits Corp. (a)

157,393

1,174,152

ARM Holdings PLC sponsored ADR

19

888

Atmel Corp. (a)

11,952

77,329

Avago Technologies Ltd.

205

6,552

Broadcom Corp. Class A

2,304

82,944

Canadian Solar, Inc. (a)

32

180

Cavium, Inc. (a)

132,590

4,169,956

Chipbond Technology Corp.

248,000

630,722

ChipMOS TECHNOLOGIES (Bermuda) Ltd.

66,837

984,509

Cirrus Logic, Inc. (a)

3,406

65,770

Cree, Inc. (a)

51,787

2,929,591

Cypress Semiconductor Corp.

205,929

2,077,824

Dialog Semiconductor PLC (a)

3,866

45,924

Diodes, Inc. (a)

370

7,496

Fairchild Semiconductor International, Inc. (a)

565

7,289

Freescale Semiconductor Holdings I Ltd. (a)

47,858

740,842

Hittite Microwave Corp. (a)

147

8,248

Infineon Technologies AG

1,000

7,895

Inotera Memories, Inc. (a)

9,575,000

3,766,362

Inphi Corp. (a)

126,857

1,193,724

International Rectifier Corp. (a)

9,649

204,655

Intersil Corp. Class A

23,794

184,641

JA Solar Holdings Co. Ltd. ADR (a)(d)

8,186

41,257

Linear Technology Corp.

185

6,753

 

Shares

Value

LSI Corp. (a)

116,195

$ 759,915

MagnaChip Semiconductor Corp. (a)

64

1,027

Marvell Technology Group Ltd.

566

6,090

MediaTek, Inc.

1,522

18,580

Mellanox Technologies Ltd. (a)

31,900

1,626,262

Micron Technology, Inc. (a)

805,258

7,585,530

Microsemi Corp. (a)

4,100

85,280

Mindspeed Technologies, Inc. (a)(d)

161,476

369,780

Monolithic Power Systems, Inc.

121,798

2,937,768

MStar Semiconductor, Inc.

56,000

478,535

Novatek Microelectronics Corp.

257,000

1,254,934

NVIDIA Corp.

6,070

83,584

NXP Semiconductors NV (a)

51,933

1,430,754

O2Micro International Ltd. sponsored ADR (a)

14,600

49,932

Omnivision Technologies, Inc. (a)

214,777

2,880,160

ON Semiconductor Corp. (a)

408,226

3,208,656

Phison Electronics Corp.

101,000

796,287

PMC-Sierra, Inc. (a)

212,399

1,223,418

Power Integrations, Inc.

4,924

203,903

Radiant Opto-Electronics Corp.

2,550

10,376

Rambus, Inc. (a)

156,707

1,090,681

RDA Microelectronics, Inc. sponsored ADR

15,172

144,741

RF Micro Devices, Inc. (a)

189,111

1,060,913

Samsung Electronics Co. Ltd.

2

2,760

Semtech Corp. (a)

24,103

772,983

Silicon Laboratories, Inc. (a)

1,700

67,507

Silicon Motion Technology Corp. sponsored ADR

66

719

Siliconware Precision Industries Co. Ltd. sponsored ADR

53,700

327,033

SK Hynix, Inc.

17,460

473,901

Skyworks Solutions, Inc. (a)

139,231

3,072,828

Spreadtrum Communications, Inc. ADR

192,397

4,205,798

STMicroelectronics NV (NY Shares) unit

1,000

8,680

Texas Instruments, Inc.

2,850

103,199

Trina Solar Ltd. (a)(d)

10,094

51,580

Xilinx, Inc.

81,744

3,098,915

YoungTek Electronics Corp.

1,156

2,924

 

71,832,447

TOTAL SEMICONDUCTORS & SEMICONDUCTOR EQUIPMENT

82,101,168

SOFTWARE - 21.7%

Application Software - 10.6%

Adobe Systems, Inc. (a)

165,949

7,480,981

ANSYS, Inc. (a)

33,753

2,729,268

AsiaInfo-Linkage, Inc. (a)

80,556

924,783

Aspen Technology, Inc. (a)

108,321

3,301,624

Autodesk, Inc. (a)

41,108

1,618,833

Blackbaud, Inc.

2,435

71,370

BroadSoft, Inc. (a)

143,027

3,655,770

Common Stocks - continued

Shares

Value

SOFTWARE - CONTINUED

Application Software - continued

Citrix Systems, Inc. (a)

18,187

$ 1,130,686

Compuware Corp. (a)

230,453

2,765,436

Comverse, Inc.

4,710

124,956

Concur Technologies, Inc. (a)(d)

49,105

3,590,067

Descartes Systems Group, Inc. (a)

219,300

2,176,783

Ellie Mae, Inc. (a)

18,469

480,563

Guidewire Software, Inc. (a)

53,300

2,136,264

Informatica Corp. (a)

2,233

73,533

Intuit, Inc.

99

5,904

Jive Software, Inc. (a)

110,500

1,501,695

Kingdee International Software Group Co. Ltd. (a)

13,250,800

2,185,657

Manhattan Associates, Inc. (a)

97

6,810

MicroStrategy, Inc. Class A (a)

17,560

1,583,736

Nuance Communications, Inc. (a)

193,905

3,691,951

Parametric Technology Corp. (a)

135,095

3,243,631

Pegasystems, Inc.

23,421

592,786

PROS Holdings, Inc. (a)

8,633

223,767

QLIK Technologies, Inc. (a)

62,987

1,638,292

RealPage, Inc. (a)

4,600

93,840

salesforce.com, Inc. (a)

592,603

24,361,909

SAP AG

125

9,965

SolarWinds, Inc. (a)

15,214

773,632

Splunk, Inc.

200

8,160

Synchronoss Technologies, Inc. (a)

75,348

2,135,362

Synopsys, Inc. (a)

2,500

88,925

TIBCO Software, Inc. (a)

174,116

3,379,592

TiVo, Inc. (a)

8,000

93,760

Ultimate Software Group, Inc. (a)

20,100

1,941,459

Verint Systems, Inc. (a)

6,115

202,040

Workday, Inc. Class A

5,600

350,840

 

80,374,630

Home Entertainment Software - 1.9%

Activision Blizzard, Inc.

341,770

5,109,462

Capcom Co. Ltd. (d)

107,300

1,762,503

Nintendo Co. Ltd.

31,000

3,421,551

Nintendo Co. Ltd. ADR

50,900

699,875

Perfect World Co. Ltd. sponsored ADR Class B

187,775

2,249,545

Square Enix Holdings Co. Ltd.

35,000

430,141

Take-Two Interactive Software, Inc. (a)

53,923

822,865

 

14,495,942

Systems Software - 9.2%

Allot Communications Ltd. (a)

20,200

228,664

BMC Software, Inc. (a)

1,824

82,956

Check Point Software Technologies Ltd. (a)

13

606

CommVault Systems, Inc. (a)

35,215

2,589,711

 

Shares

Value

Fortinet, Inc. (a)

442

$ 7,938

Imperva, Inc. (a)

11,600

452,168

Infoblox, Inc.

3,000

66,330

Insyde Software Corp.

304,000

540,170

Microsoft Corp.

118,831

3,933,306

NetSuite, Inc. (a)

47,618

4,188,479

Oracle Corp.

1,307,750

42,868,045

Red Hat, Inc. (a)

121,551

5,825,939

ServiceNow, Inc.

12,500

512,000

Sourcefire, Inc. (a)

52,530

2,508,833

Symantec Corp. (a)

584

14,191

Totvs SA

72,900

1,370,735

VMware, Inc. Class A (a)

63,407

4,470,194

 

69,660,265

TOTAL SOFTWARE

164,530,837

WIRELESS TELECOMMUNICATION SERVICES - 0.7%

Wireless Telecommunication Services - 0.7%

SBA Communications Corp. Class A (a)

71,029

5,610,581

TOTAL COMMON STOCKS

(Cost $734,765,257)


746,555,506

Convertible Bonds - 0.5%

 

Principal
Amount

 

COMMUNICATIONS EQUIPMENT - 0.2%

Communications Equipment - 0.2%

Ciena Corp. 0.25% 5/1/13

$ 1,270,000

1,254,887

SEMICONDUCTORS & SEMICONDUCTOR EQUIPMENT - 0.3%

Semiconductors - 0.3%

JA Solar Holdings Co. Ltd. 4.5% 5/15/13

2,179,000

2,059,155

TOTAL CONVERTIBLE BONDS

(Cost $3,433,356)


3,314,042

Money Market Funds - 2.6%

 

 

Fidelity Cash Central Fund, 0.13% (b)

9,513,429

9,513,429

Fidelity Securities Lending Cash Central Fund, 0.12% (b)(c)

10,418,665

10,418,665

TOTAL MONEY MARKET FUNDS

(Cost $19,932,094)


19,932,094

TOTAL INVESTMENT PORTFOLIO - 101.6%

(Cost $758,130,707)

769,801,642

NET OTHER ASSETS (LIABILITIES) - (1.6)%

(11,787,045 )

NET ASSETS - 100%

$ 758,014,597

Legend

(a) Non-income producing

(b) Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.

(c) Investment made with cash collateral received from securities on loan.

(d) Security or a portion of the security is on loan at period end.

(e) Security exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers. At the end of the period, the value of these securities amounted to $48,600 or 0.0% of net assets.

Affiliated Central Funds

Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:

Fund

Income earned

Fidelity Cash Central Fund

$ 55,004

Fidelity Securities Lending Cash Central Fund

235,711

Total

$ 290,715

Other Information

The following is a summary of the inputs used, as of April 30, 2013, involving the Fund's assets and liabilities carried at fair value. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. For more information on valuation inputs, and their aggregation into the levels used in the tables below, please refer to the Investment Valuation section at the end of this listing.

Valuation Inputs at Reporting Date:

Description

Total

Level 1

Level 2

Level 3

Investments in Securities:

Common Stocks

$ 746,555,506

$ 722,674,608

$ 23,880,898

$ -

Convertible Bonds

3,314,042

-

3,314,042

-

Money Market Funds

19,932,094

19,932,094

-

-

Total Investments in Securities:

$ 769,801,642

$ 742,606,702

$ 27,194,940

$ -

Income Tax Information

At April 30, 2013, the cost of investment securities for income tax purposes was $762,348,321. Net unrealized appreciation aggregated $7,453,321, of which $67,912,256 related to appreciated investment securities and $60,458,935 related to depreciated investment securities.

Investment Valuation

Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. In accordance with valuation policies and procedures approved by the Board of Trustees (the Board), the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Fidelity Management & Research Company (FMR) Fair Value Committee (the Committee), in accordance with procedures adopted by the Fund's Board. Factors used in determining fair value vary by investment type and may include market or investment specific events, changes in interest rates and credit quality. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund's valuation policies and procedures and is responsible for approving and reporting to the Board all fair value determinations. The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels: Level 1 - quoted prices in active markets for identical investments: Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds etc.): Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available). Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the Fund's investments by major category are as follows:

Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy in these circumstances. Utilizing these techniques may result in transfers between Level 1 and Level 2.

Debt securities, including restricted securities, are valued based on evaluated prices received from third party pricing vendors or from brokers who make markets in such securities. For corporate bonds, pricing vendors utilize matrix pricing which considers yield or price of bonds of comparable quality, coupon, maturity and type as well as broker-supplied prices.

When independent prices are unavailable or unreliable, debt securities may be valued utilizing pricing methodologies which consider similar factors that would be used by third party pricing vendors. Debt securities are generally categorized as Level 2 in the hierarchy but may be Level 3 depending on the circumstances.

Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value each business day and are categorized as Level 1 in the hierarchy.

For additional information on the Fund's policy regarding valuation of investments and other significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.

Quarterly Report

The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please visit advisor.fidelity.com or call Fidelity at 1-877-208-0098 for a free copy of the fund's most recent prospectus and annual report.

Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.

Quarterly Report

Quarterly Holdings Report

for

Fidelity Advisor ® Energy Fund
Class A
Class T
Class B
Class C
Institutional Class


April 30, 2013

1.800328.109
ANR-QTLY-0613

Investments April 30, 2013 (Unaudited)

Showing Percentage of Net Assets

Common Stocks - 99.3%

Shares

Value

CHEMICALS - 1.7%

Commodity Chemicals - 1.7%

LyondellBasell Industries NV Class A

135,310

$ 8,213,317

Westlake Chemical Corp.

35,291

2,934,094

 

11,147,411

ENERGY EQUIPMENT & SERVICES - 22.6%

Oil & Gas Drilling - 5.4%

Discovery Offshore S.A. (a)(e)

676,590

1,583,970

Ensco PLC Class A

332,835

19,197,923

Helmerich & Payne, Inc.

95,376

5,590,941

Noble Corp.

209,764

7,866,150

Northern Offshore Ltd.

328,887

564,637

Vantage Drilling Co. (a)

462,700

781,963

 

35,585,584

Oil & Gas Equipment & Services - 17.2%

Anton Oilfield Services Group

438,000

349,377

C&J Energy Services, Inc. (a)

14,500

286,955

Cameron International Corp. (a)

153,141

9,425,829

Core Laboratories NV (d)

34,282

4,963,348

FMC Technologies, Inc. (a)

55,100

2,991,930

Forum Energy Technologies, Inc.

83,822

2,331,090

Geospace Technologies Corp. (a)

11,032

930,770

Halliburton Co.

866,667

37,067,348

National Oilwell Varco, Inc.

384,907

25,103,635

Oceaneering International, Inc.

12,000

842,040

Schlumberger Ltd.

320,164

23,829,807

Superior Energy Services, Inc. (a)

83,484

2,303,324

Total Energy Services, Inc.

53,200

738,236

Weatherford International Ltd. (a)

117,390

1,501,418

 

112,665,107

TOTAL ENERGY EQUIPMENT & SERVICES

148,250,691

HOTELS, RESTAURANTS & LEISURE - 0.0%

Casinos & Gaming - 0.0%

Icahn Enterprises LP rights

66,553

1

OIL, GAS & CONSUMABLE FUELS - 75.0%

Coal & Consumable Fuels - 0.9%

Alpha Natural Resources, Inc. (a)

95,000

704,900

Peabody Energy Corp.

254,314

5,101,539

 

5,806,439

Integrated Oil & Gas - 35.6%

Chevron Corp.

481,510

58,749,035

Exxon Mobil Corp.

703,494

62,603,924

Hess Corp.

413,361

29,836,397

InterOil Corp. (a)(d)

55,700

4,406,984

 

Shares

Value

Murphy Oil Corp.

346,612

$ 21,521,139

Occidental Petroleum Corp.

457,256

40,814,671

Suncor Energy, Inc.

512,060

15,964,866

 

233,897,016

Oil & Gas Exploration & Production - 27.2%

Anadarko Petroleum Corp.

292,929

24,828,662

Bankers Petroleum Ltd. (a)

831,400

2,079,635

Bonanza Creek Energy, Inc. (a)

43,943

1,509,442

BPZ Energy, Inc. (a)

221,964

475,003

Cabot Oil & Gas Corp.

183,391

12,479,758

Cobalt International Energy, Inc. (a)

260,167

7,269,066

Concho Resources, Inc. (a)

235,103

20,249,421

Continental Resources, Inc. (a)

100,679

8,046,266

EOG Resources, Inc.

187,329

22,696,782

EPL Oil & Gas, Inc. (a)

72,660

2,373,802

EQT Corp.

220,900

16,594,008

EV Energy Partners LP

49,600

2,309,376

Gulfport Energy Corp. (a)

44,925

2,344,636

Halcon Resources Corp.

300,000

1,962,000

Kosmos Energy Ltd. (a)

60,000

659,400

Marathon Oil Corp.

282,104

9,216,338

Noble Energy, Inc.

143,054

16,206,588

Northern Oil & Gas, Inc. (a)

204,993

2,642,360

Oasis Petroleum, Inc. (a)

174,677

5,979,194

Painted Pony Petroleum Ltd. Class A (a)

142,700

1,385,286

PDC Energy, Inc. (a)

6,857

296,908

Pioneer Natural Resources Co.

133,419

16,307,804

Rosetta Resources, Inc. (a)

17,081

732,946

TAG Oil Ltd. (a)

77,800

424,736

 

179,069,417

Oil & Gas Refining & Marketing - 5.0%

Calumet Specialty Products Partners LP

84,391

3,186,604

Marathon Petroleum Corp.

160,387

12,567,925

Northern Tier Energy LP Class A

69,770

1,840,533

Phillips 66

187,036

11,399,844

Tesoro Corp.

37,109

1,981,621

Valero Energy Corp.

55,455

2,235,946

 

33,212,473

Oil & Gas Storage & Transport - 6.3%

Atlas Energy LP

105,950

5,318,690

Atlas Pipeline Partners LP

101,500

3,688,510

Magellan Midstream Partners LP

67,186

3,562,874

Markwest Energy Partners LP

32,400

2,047,680

Targa Resources Corp.

49,147

3,231,907

Tesoro Logistics LP

98,066

5,844,734

The Williams Companies, Inc.

459,151

17,507,428

 

41,201,823

TOTAL OIL, GAS & CONSUMABLE FUELS

493,187,168

TOTAL COMMON STOCKS

(Cost $570,599,079)


652,585,271

Money Market Funds - 2.2%

Shares

Value

Fidelity Cash Central Fund, 0.13% (b)

4,876,762

$ 4,876,762

Fidelity Securities Lending Cash Central Fund, 0.12% (b)(c)

9,345,475

9,345,475

TOTAL MONEY MARKET FUNDS

(Cost $14,222,237)


14,222,237

TOTAL INVESTMENT PORTFOLIO - 101.5%

(Cost $584,821,316)

666,807,508

NET OTHER ASSETS (LIABILITIES) - (1.5)%

(9,693,143 )

NET ASSETS - 100%

$ 657,114,365

Legend

(a) Non-income producing

(b) Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.

(c) Investment made with cash collateral received from securities on loan.

(d) Security or a portion of the security is on loan at period end.

(e) Security exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers. At the end of the period, the value of these securities amounted to $1,583,970 or 0.2% of net assets.

Affiliated Central Funds

Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:

Fund

Income earned

Fidelity Cash Central Fund

$ 5,988

Fidelity Securities Lending Cash Central Fund

190,163

Total

$ 196,151

Other Information

The following is a summary of the inputs used, as of April 30, 2013, involving the Fund's assets and liabilities carried at fair value. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. For more information on valuation inputs, and their aggregation into the levels used in the table below, please refer to the Investment Valuation section at the end of this listing.

Valuation Inputs at Reporting Date:

Description

Total

Level 1

Level 2

Level 3

Investments in Securities:

Common Stocks

$ 652,585,271

$ 652,585,270

$ -

$ 1

Money Market Funds

14,222,237

14,222,237

-

-

Total Investments in Securities:

$ 666,807,508

$ 666,807,507

$ -

$ 1

Income Tax Information

At April 30, 2013, the cost of investment securities for income tax purposes was $587,905,274. Net unrealized appreciation aggregated $78,902,234, of which $94,879,775 related to appreciated investment securities and $15,977,541 related to depreciated investment securities.

Investment Valuation

Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. In accordance with valuation policies and procedures approved by the Board of Trustees (the Board), the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Fidelity Management & Research Company (FMR) Fair Value Committee (the Committee), in accordance with procedures adopted by the Fund's Board. Factors used in determining fair value vary by investment type and may include market or investment specific events. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund's valuation policies and procedures and is responsible for approving and reporting to the Board all fair value determinations. The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels: Level 1 - quoted prices in active markets for identical investments: Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds etc.): Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available). Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the Fund's investments by major category are as follows:

Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy in these circumstances. Utilizing these techniques may result in transfers between Level 1 and Level 2.

Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value each business day and are categorized as Level 1 in the hierarchy.

For additional information on the Fund's policy regarding valuation of investments and other significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.

Quarterly Report

The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please visit advisor.fidelity.com or call Fidelity at 1-877-208-0098 for a free copy of the fund's most recent prospectus and annual report.

Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.

Quarterly Report

Quarterly Holdings Report

for

Fidelity Advisor ® Biotechnology Fund
Class A
Class T
Class B
Class C
Institutional Class


April 30, 2013

1.800321.109
AFBT-QTLY-0613

Investments April 30, 2013 (Unaudited)

Showing Percentage of Net Assets

Common Stocks - 98.5%

Shares

Value

BIOTECHNOLOGY - 96.6%

Biotechnology - 96.6%

A.P. Pharma, Inc. (e)

743,765

$ 270,730

ACADIA Pharmaceuticals, Inc. (a)(d)

350,386

4,516,476

Achillion Pharmaceuticals, Inc. (a)

142,589

1,075,121

Acorda Therapeutics, Inc. (a)

142,905

5,654,751

Aegerion Pharmaceuticals, Inc. (a)

144,620

6,079,825

Affymax, Inc. (a)(d)

5,087

4,579

Agenus, Inc. (a)

9,425

45,806

Agenus, Inc. warrants 6/9/18 (a)(e)

452,000

35,765

Alexion Pharmaceuticals, Inc. (a)

238,563

23,379,174

Alkermes PLC (a)

128,761

3,941,374

Alnylam Pharmaceuticals, Inc. (a)

122,498

2,933,827

AMAG Pharmaceuticals, Inc. (a)

48,069

1,059,921

Amgen, Inc.

619,514

64,559,551

Arena Pharmaceuticals, Inc. (a)(d)

245,729

2,024,807

ARIAD Pharmaceuticals, Inc. (a)

188,106

3,361,454

ArQule, Inc. (a)

192,550

568,023

AVEO Pharmaceuticals, Inc. (a)(d)

134,829

688,976

Biogen Idec, Inc. (a)

135,526

29,670,707

BioMarin Pharmaceutical, Inc. (a)

165,738

10,872,413

Bionovo, Inc. warrants 2/2/16 (a)

56,850

138

BioTime, Inc. (a)(d)

111,305

402,924

Catalyst Pharmaceutical Partners, Inc.:

warrants 5/2/17 (a)

8,557

3

warrants 5/30/17 (a)

17,900

103

Celgene Corp. (a)

274,183

32,372,787

Cell Therapeutics, Inc. (d)

473,147

539,388

Cell Therapeutics, Inc. warrants 7/6/16 (a)

46,404

656

Celldex Therapeutics, Inc. (a)

157,995

2,061,835

Cepheid, Inc. (a)

55,200

2,104,776

Chimerix, Inc.

3,400

67,762

Clovis Oncology, Inc. (a)(d)

48,888

1,829,389

Cubist Pharmaceuticals, Inc. (a)

66,292

3,044,129

Curis, Inc. (a)

142,839

535,646

Cytokinetics, Inc.

407,500

521,600

Cytokinetics, Inc. warrants 6/25/17 (a)

244,500

62,450

Dendreon Corp. (a)(d)

190,903

899,153

Dyax Corp. (a)

414,791

1,140,675

Dynavax Technologies Corp. (a)

160,269

376,632

Elan Corp. PLC sponsored ADR (a)

109,652

1,282,928

Emergent BioSolutions, Inc. (a)

17,500

268,450

Enzon Pharmaceuticals, Inc.

8,434

27,832

Exact Sciences Corp. (a)

55,900

522,106

Exelixis, Inc. (a)(d)

96,345

500,031

Fibrocell Science, Inc. (e)

174,200

695,058

Genomic Health, Inc. (a)

20,528

623,230

Geron Corp. (a)

427,965

500,719

Gilead Sciences, Inc. (a)

1,205,794

61,061,408

Halozyme Therapeutics, Inc. (a)

160,032

966,593

Hyperion Therapeutics, Inc.

93,363

2,002,636

 

Shares

Value

Idenix Pharmaceuticals, Inc. (a)(d)

58,586

$ 216,768

ImmunoGen, Inc. (a)(d)

83,980

1,345,360

Immunomedics, Inc. (a)(d)

127,450

326,272

Incyte Corp. (a)(d)

126,332

2,798,254

Infinity Pharmaceuticals, Inc. (a)

72,134

3,108,254

Intercept Pharmaceuticals, Inc.

8,867

301,921

InterMune, Inc. (a)(d)

252,918

2,359,725

Ironwood Pharmaceuticals, Inc. Class A (a)(d)

344,251

5,236,058

Isis Pharmaceuticals, Inc. (a)(d)

113,147

2,533,361

KaloBios Pharmaceuticals, Inc.

13,602

73,451

KaloBios Pharmaceuticals, Inc.

17,700

106,200

Lexicon Pharmaceuticals, Inc. (a)

543,326

1,075,785

Ligand Pharmaceuticals, Inc. Class B (a)

52,183

1,425,640

MannKind Corp. (a)(d)

504,208

1,991,622

Medivation, Inc. (a)

156,948

8,272,729

Merrimack Pharmaceuticals, Inc. (a)

2,800

13,776

Momenta Pharmaceuticals, Inc. (a)

39,166

482,525

Myriad Genetics, Inc. (a)

68,082

1,896,084

Neurocrine Biosciences, Inc. (a)

194,998

2,250,277

NeurogesX, Inc. (a)

187,202

2,583

NewLink Genetics Corp. (a)(d)

63,087

879,433

Novavax, Inc. (a)

586,056

1,377,232

Novelos Therapeutics, Inc. (a)

137,600

59,168

Novelos Therapeutics, Inc. warrants 12/6/16 (a)

137,600

267

NPS Pharmaceuticals, Inc. (a)

146,953

1,973,579

OncoGenex Pharmaceuticals, Inc. (a)

7,005

70,961

Onyx Pharmaceuticals, Inc. (a)

104,305

9,888,114

Opko Health, Inc. (a)(d)

159,000

1,058,940

Oragenics, Inc. (e)

108,608

369,267

Orexigen Therapeutics, Inc. (a)

275,109

1,672,663

Osiris Therapeutics, Inc. (a)(d)

70,287

788,620

OvaScience, Inc. (a)

12,800

149,760

PDL BioPharma, Inc. (d)

99,788

772,359

Pharmacyclics, Inc. (a)

84,676

6,901,094

PolyMedix, Inc. (a)

7,142

786

PolyMedix, Inc. warrants 4/10/16 (a)

163,833

2

Progenics Pharmaceuticals, Inc. (a)

490,109

2,254,501

Protalix BioTherapeutics, Inc. (a)(d)

90,943

515,647

Puma Biotechnology, Inc. (a)

42,757

1,375,920

Raptor Pharmaceutical Corp. (a)(d)

245,273

1,692,384

Regeneron Pharmaceuticals, Inc. (a)

92,204

19,836,769

Rigel Pharmaceuticals, Inc. (a)

75,572

361,990

Sangamo Biosciences, Inc. (a)(d)

147,070

1,497,173

Sarepta Therapeutics, Inc. (a)(d)

20,462

594,216

Savient Pharmaceuticals, Inc. (a)(d)

118,216

88,225

Seattle Genetics, Inc. (a)(d)

142,093

5,250,336

SIGA Technologies, Inc. (a)(d)

128,486

424,004

Sophiris Bio, Inc.

138,000

30,135

Sorrento Therapeutics, Inc. (e)

720,000

154,800

Spectrum Pharmaceuticals, Inc. (d)

363,247

2,691,660

Stemline Therapeutics, Inc.

36,900

529,146

Common Stocks - continued

Shares

Value

BIOTECHNOLOGY - CONTINUED

Biotechnology - continued

Sunesis Pharmaceuticals, Inc. (a)(d)

159,517

$ 898,081

Synageva BioPharma Corp. (a)

19,200

992,448

Synergy Pharmaceuticals, Inc. (a)

111,988

587,937

Synergy Pharmaceuticals, Inc. warrants 11/14/16 (a)

20,600

48,616

Synta Pharmaceuticals Corp. (a)(d)

159,002

1,629,771

Synthetic Biologics, Inc. (a)

100

146

Targacept, Inc. (a)

142,026

654,740

TESARO, Inc. (d)

66,803

1,837,751

Theravance, Inc. (a)(d)

122,236

4,125,465

Threshold Pharmaceuticals, Inc. (a)

92,584

446,255

Threshold Pharmaceuticals, Inc. warrants 3/16/16 (a)

35,146

100,739

Trius Therapeutics, Inc. (a)

131,738

918,214

United Therapeutics Corp. (a)

60,052

4,010,273

Verastem, Inc. (a)

6,365

62,504

Vertex Pharmaceuticals, Inc. (a)

255,373

19,617,754

Vical, Inc. (a)

321,877

1,187,726

ZIOPHARM Oncology, Inc. (a)(d)

227,379

381,997

 

411,730,530

HEALTH CARE EQUIPMENT & SUPPLIES - 0.1%

Health Care Equipment - 0.1%

Alsius Corp. (a)

14,200

0

Aradigm Corp. (a)

351,440

38,658

InVivo Therapeutics Holdings Corp. (a)

98,300

304,730

 

343,388

LIFE SCIENCES TOOLS & SERVICES - 0.1%

Life Sciences Tools & Services - 0.1%

BG Medicine, Inc. (a)

75,570

124,691

ChromaDex, Inc. (a)

143,866

92,074

Transgenomic, Inc. (a)

33,100

12,247

Transgenomic, Inc. (a)(e)

162,000

59,940

Transgenomic, Inc. warrants 2/3/17 (a)(e)

81,000

1

 

288,953

PERSONAL PRODUCTS - 0.0%

Personal Products - 0.0%

MYOS Corp. (e)

333,300

43,329

PHARMACEUTICALS - 1.7%

Pharmaceuticals - 1.7%

AcelRx Pharmaceuticals, Inc. (a)(d)

52,410

307,123

Auxilium Pharmaceuticals, Inc. (a)

46,358

692,125

AVANIR Pharmaceuticals Class A (a)(d)

379,315

1,210,015

Horizon Pharma, Inc. (a)(d)

116,600

279,840

Horizon Pharma, Inc.:

warrants 2/28/17 (a)

18,737

7

warrants 9/25/17 (a)

55,250

19

Jazz Pharmaceuticals PLC (a)

36,220

2,113,437

 

Shares

Value

Pacira Pharmaceuticals, Inc. (a)

68,821

$ 1,986,862

TherapeuticsMD, Inc. (a)

113,400

285,768

XenoPort, Inc. (a)

81

503

Zogenix, Inc. (a)

181,384

313,794

Zogenix, Inc. warrants 7/27/17 (a)

32,985

130

 

7,189,623

TOTAL COMMON STOCKS

(Cost $309,460,764)


419,595,823

Convertible Preferred Stocks - 0.2%

 

 

 

 

BIOTECHNOLOGY - 0.0%

Biotechnology - 0.0%

bluebird bio (e)

35,360

27,450

Intrexon Corp. 6.00% (e)

19,884

156,587

 

184,037

PHARMACEUTICALS - 0.2%

Pharmaceuticals - 0.2%

Agios Pharmaceuticals, Inc. Series C (a)(e)

13,990

68,706

aTyr Pharma, Inc. 8.00% (e)

247,934

627,025

 

695,731

TOTAL CONVERTIBLE PREFERRED STOCKS

(Cost $869,938)


879,768

Money Market Funds - 6.4%

 

 

 

 

Fidelity Cash Central Fund, 0.13% (b)

7,476,511

7,476,511

Fidelity Securities Lending Cash Central Fund, 0.12% (b)(c)

19,607,492

19,607,492

TOTAL MONEY MARKET FUNDS

(Cost $27,084,003)


27,084,003

TOTAL INVESTMENT PORTFOLIO - 105.1%

(Cost $337,414,705)

447,559,594

NET OTHER ASSETS (LIABILITIES) - (5.1)%

(21,595,672 )

NET ASSETS - 100%

$ 425,963,922

Legend

(a) Non-income producing

(b) Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.

(c) Investment made with cash collateral received from securities on loan.

(d) Security or a portion of the security is on loan at period end.

(e) Restricted securities - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues). At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $2,508,658 or 0.6% of net assets.

Additional information on each restricted holding is as follows:

Security

Acquisition Date

Acquisition Cost

A.P. Pharma, Inc.

7/25/12

$ 390,477

Agenus, Inc. warrants 6/9/18

1/9/08

$ 563,722

Agios Pharmaceuticals, Inc. Series C

11/16/11

$ 68,706

aTyr Pharma, Inc. 8.00%

4/8/13

$ 627,025

bluebird bio

7/23/12

$ 17,620

Fibrocell Science, Inc.

10/8/12

$ 435,500

Intrexon Corp. 6.00%

4/30/13

$ 156,587

MYOS Corp.

7/2/12

$ 83,325

Oragenics, Inc.

7/31/12

$ 162,912

Sorrento Therapeutics, Inc.

5/15/12

$ 115,200

Transgenomic, Inc.

2/3/12

$ 161,441

Transgenomic, Inc. warrants 2/3/17

2/3/12

$ 559

Affiliated Central Funds

Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:

Fund

Income earned

Fidelity Cash Central Fund

$ 8,920

Fidelity Securities Lending Cash Central Fund

596,086

Total

$ 605,006

Other Information

The following is a summary of the inputs used, as of April 30, 2013, involving the Fund's assets and liabilities carried at fair value. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. For more information on valuation inputs, and their aggregation into the levels used in the table below, please refer to the Investment Valuation section at the end of this listing.

Valuation Inputs at Reporting Date:

Description

Total

Level 1

Level 2

Level 3

Investments in Securities:

Common Stocks

$ 419,595,823

$ 419,322,092

$ 273,731

$ -

Convertible Preferred Stocks

879,768

-

-

879,768

Money Market Funds

27,084,003

27,084,003

-

-

Total Investments in Securities:

$ 447,559,594

$ 446,406,095

$ 273,731

$ 879,768

Income Tax Information

At April 30, 2013, the cost of investment securities for income tax purposes was $338,382,525. Net unrealized appreciation aggregated $109,177,069, of which $122,945,526 related to appreciated investment securities and $13,768,457 related to depreciated investment securities.

Investment Valuation

Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. In accordance with valuation policies and procedures approved by the Board of Trustees (the Board), the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Fidelity Management & Research Company (FMR) Fair Value Committee (the Committee), in accordance with procedures adopted by the Fund's Board. Factors used in determining fair value vary by investment type and may include market or investment specific events. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund's valuation policies and procedures and is responsible for approving and reporting to the Board all fair value determinations. The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels: Level 1 - quoted prices in active markets for identical investments: Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds etc.): Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available). Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the Fund's investments by major category are as follows:

Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy in these circumstances. Utilizing these techniques may result in transfers between Level 1 and Level 2. For restricted equity securities and private placements where observable inputs are limited, assumptions about market activity and risk are used and these securities are generally categorized as Level 3 in the hierarchy.

Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value each business day and are categorized as Level 1 in the hierarchy.

For additional information on the Fund's policy regarding valuation of investments and other significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.

Quarterly Report

The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please visit advisor.fidelity.com or call Fidelity at 1-877-208-0098 for a free copy of the fund's most recent prospectus and annual report.

Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.

Quarterly Report

Quarterly Holdings Report

For

Fidelity Advisor ® Electronics Fund
Class A
Class T
Class B
Class C
Institutional Class


April 30, 2013

1.800325.109
AFEL-QTLY-0613

Investments April 30, 2013 (Unaudited)

Showing Percentage of Net Assets

Common Stocks - 94.9%

Shares

Value

BIOTECHNOLOGY - 0.0%

Biotechnology - 0.0%

Arrowhead Research Corp. warrants 5/21/17 (a)(f)

64,879

$ 1

COMMERCIAL SERVICES & SUPPLIES - 0.3%

Office Services & Supplies - 0.3%

West Corp.

1,918

40,278

COMMUNICATIONS EQUIPMENT - 7.8%

Communications Equipment - 7.8%

Brocade Communications Systems, Inc. (a)

4,678

27,226

F5 Networks, Inc. (a)

500

38,215

Finisar Corp. (a)

3,070

39,419

Juniper Networks, Inc. (a)

4,121

68,203

NETGEAR, Inc. (a)

1,400

41,706

Polycom, Inc. (a)

10,596

111,258

QUALCOMM, Inc.

9,157

564,254

Radware Ltd. (a)

1,856

27,821

Research In Motion Ltd. (a)

1,440

23,458

Riverbed Technology, Inc. (a)

6,025

89,532

 

1,031,092

COMPUTERS & PERIPHERALS - 2.7%

Computer Hardware - 2.2%

Apple, Inc.

540

239,085

Hewlett-Packard Co.

2,536

52,242

 

291,327

Computer Storage & Peripherals - 0.5%

EMC Corp. (a)

2,033

45,600

SanDisk Corp. (a)

400

20,976

 

66,576

TOTAL COMPUTERS & PERIPHERALS

357,903

ELECTRONIC EQUIPMENT & COMPONENTS - 10.8%

Electronic Components - 1.9%

Aeroflex Holding Corp. (a)

23,890

177,742

Corning, Inc.

410

5,945

InvenSense, Inc. (a)

6,898

64,289

 

247,976

Electronic Manufacturing Services - 8.9%

Benchmark Electronics, Inc. (a)

3,150

56,196

Flextronics International Ltd. (a)

36,581

261,554

Jabil Circuit, Inc.

31,787

565,809

TTM Technologies, Inc. (a)

39,141

282,989

Viasystems Group, Inc. (a)

12

153

 

1,166,701

TOTAL ELECTRONIC EQUIPMENT & COMPONENTS

1,414,677

 

Shares

Value

INTERNET SOFTWARE & SERVICES - 0.6%

Internet Software & Services - 0.6%

Demand Media, Inc. (a)

4,275

$ 37,022

Facebook, Inc. Class A

1,192

33,090

Velti PLC (a)

5,600

11,200

 

81,312

IT SERVICES - 0.6%

Data Processing & Outsourced Services - 0.6%

EVERTEC, Inc.

1,386

27,789

VeriFone Systems, Inc. (a)

2,227

47,836

 

75,625

SEMICONDUCTORS & SEMICONDUCTOR EQUIPMENT - 71.2%

Semiconductor Equipment - 0.6%

Amkor Technology, Inc. (a)

3,357

14,200

GT Advanced Technologies, Inc. (a)

7,609

29,903

Lam Research Corp. (a)

382

17,656

Rubicon Technology, Inc. (a)

2,754

20,407

 

82,166

Semiconductors - 70.6%

Advanced Micro Devices, Inc. (a)(d)

43,558

122,834

Alpha & Omega Semiconductor Ltd. (a)

589

4,264

Altera Corp.

29,594

947,304

Analog Devices, Inc.

10,940

481,251

Atmel Corp. (a)

7,012

45,368

Avago Technologies Ltd.

27,276

871,741

Broadcom Corp. Class A

31,355

1,128,774

Cypress Semiconductor Corp.

31,095

313,749

Entropic Communications, Inc. (a)

9,744

41,315

EZchip Semiconductor Ltd. (a)

4,034

92,016

First Solar, Inc. (a)

1,984

92,375

Freescale Semiconductor Holdings I Ltd. (a)(d)

19,004

294,182

Infineon Technologies AG

2,500

19,738

Inphi Corp. (a)

11,900

111,979

Intel Corp.

21,974

526,277

Intermolecular, Inc. (a)

4,025

35,058

Intersil Corp. Class A

79,060

613,506

LSI Corp. (a)

52,103

340,754

M/A-COM Technology Solutions, Inc. (a)

2,083

29,224

Marvell Technology Group Ltd.

58,701

631,623

MediaTek, Inc.

3,000

36,623

Micron Technology, Inc. (a)

32,198

303,305

Motech Industries, Inc. (a)

1

1

NVIDIA Corp.

26,488

364,740

NXP Semiconductors NV (a)

17,969

495,046

O2Micro International Ltd. sponsored ADR (a)

11,711

40,052

ON Semiconductor Corp. (a)

40,705

319,941

PMC-Sierra, Inc. (a)

45,013

259,275

RDA Microelectronics, Inc. sponsored ADR

4,200

40,068

Skyworks Solutions, Inc. (a)

26,526

585,429

Common Stocks - continued

Shares

Value

SEMICONDUCTORS & SEMICONDUCTOR EQUIPMENT - CONTINUED

Semiconductors - continued

Spreadtrum Communications, Inc. ADR

9

$ 197

Trident Microsystems, Inc. (a)

19

0

Volterra Semiconductor Corp. (a)

5,611

72,999

 

9,261,008

TOTAL SEMICONDUCTORS & SEMICONDUCTOR EQUIPMENT

9,343,174

SOFTWARE - 0.9%

Application Software - 0.5%

BroadSoft, Inc. (a)

753

19,247

Nuance Communications, Inc. (a)

2,543

48,419

 

67,666

Systems Software - 0.4%

Allot Communications Ltd. (a)

4,143

46,899

TOTAL SOFTWARE

114,565

TOTAL COMMON STOCKS

(Cost $15,183,685)


12,458,627

Convertible Bonds - 2.4%

 

Principal Amount

 

SEMICONDUCTORS & SEMICONDUCTOR EQUIPMENT - 2.4%

Semiconductors - 2.4%

Micron Technology, Inc.:

1.625% 2/15/33 (e)

$ 30,000

34,088

1.875% 8/1/31

83,000

93,686

3.125% 5/1/32 (e)

155,000

187,647

TOTAL CONVERTIBLE BONDS

(Cost $252,590)


315,421

Money Market Funds - 5.8%

Shares

Value

Fidelity Cash Central Fund, 0.13% (b)

340,773

$ 340,773

Fidelity Securities Lending Cash Central Fund, 0.12% (b)(c)

411,039

411,039

TOTAL MONEY MARKET FUNDS

(Cost $751,812)


751,812

TOTAL INVESTMENT PORTFOLIO - 103.1%

(Cost $16,188,087)

13,525,860

NET OTHER ASSETS (LIABILITIES) - (3.1)%

(400,546 )

NET ASSETS - 100%

$ 13,125,314

Legend

(a) Non-income producing

(b) Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.

(c) Investment made with cash collateral received from securities on loan.

(d) Security or a portion of the security is on loan at period end.

(e) Security exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers. At the end of the period, the value of these securities amounted to $221,735 or 1.7% of net assets.

(f) Restricted securities - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues). At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $1 or 0.0% of net assets.

Additional information on each restricted holding is as follows:

Security

Acquisition Date

Acquisition Cost

Arrowhead Research Corp. warrants 5/21/17

5/18/07

$ 234,942

Affiliated Central Funds

Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:

Fund

Income earned

Fidelity Cash Central Fund

$ 585

Fidelity Securities Lending Cash Central Fund

3,350

Total

$ 3,935

Other Information

The following is a summary of the inputs used, as of April 30, 2013, involving the Fund's assets and liabilities carried at fair value. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. For more information on valuation inputs, and their aggregation into the levels used in the table below, please refer to the Investment Valuation section at the end of this listing.

Valuation Inputs at Reporting Date:

Description

Total

Level 1

Level 2

Level 3

Investments in Securities:

Common Stocks

$ 12,458,627

$ 12,458,626

$ 1

$ -

Convertible Bonds

315,421

-

315,421

-

Money Market Funds

751,812

751,812

-

-

Total Investments in Securities:

$ 13,525,860

$ 13,210,438

$ 315,422

$ -

Income Tax Information

At April 30, 2013, the cost of investment securities for income tax purposes was $16,436,797. Net unrealized depreciation aggregated $2,910,937, of which $194,290 related to appreciated investment securities and $3,105,227 related to depreciated investment securities.

Investment Valuation

Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. In accordance with valuation policies and procedures approved by the Board of Trustees (the Board), the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Fidelity Management & Research Company (FMR) Fair Value Committee (the Committee), in accordance with procedures adopted by the Fund's Board. Factors used in determining fair value vary by investment type and may include market or investment specific events, changes in interest rates and credit quality. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund's valuation policies and procedures and is responsible for approving and reporting to the Board all fair value determinations. The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels: Level 1 - quoted prices in active markets for identical investments: Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds etc.): Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available). Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the Fund's investments by major category are as follows:

Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy in these circumstances. Utilizing these techniques may result in transfers between Level 1 and Level 2. For restricted equity securities and private placements where observable inputs are limited, assumptions about market activity and risk are used and these securities are generally categorized as Level 3 in the hierarchy.

Debt securities, including restricted securities, are valued based on evaluated prices received from third party pricing vendors or from brokers who make markets in such securities. For corporate bonds, pricing vendors utilize matrix pricing which considers yield or price of bonds of comparable quality, coupon, maturity and type as well as broker-supplied prices.

When independent prices are unavailable or unreliable, debt securities may be valued utilizing pricing methodologies which consider similar factors that would be used by third party pricing vendors. Debt securities are generally categorized as Level 2 in the hierarchy but may be Level 3 depending on the circumstances.

Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value each business day and are categorized as Level 1 in the hierarchy.

For additional information on the Fund's policy regarding valuation of investments and other significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.

Quarterly Report

The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please visit advisor.fidelity.com or call Fidelity at 1-877-208-0098 for a free copy of the fund's most recent prospectus and annual report.

Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.

Quarterly Report

Quarterly Holdings Report

for

Fidelity Advisor ® Industrials Fund
Class A
Class T
Class B
Class C
Institutional Class


April 30, 2013

1.800323.109
AFCY-QTLY-0613

Investments April 30, 2013 (Unaudited)

Showing Percentage of Net Assets

Common Stocks - 99.3%

Shares

Value

AEROSPACE & DEFENSE - 15.7%

Aerospace & Defense - 15.7%

Honeywell International, Inc.

250,492

$ 18,421,182

Precision Castparts Corp.

55,193

10,557,869

Teledyne Technologies, Inc. (a)

95,031

7,133,027

Textron, Inc.

245,340

6,317,505

United Technologies Corp.

339,132

30,959,360

 

73,388,943

AUTO COMPONENTS - 1.4%

Auto Parts & Equipment - 1.4%

Johnson Controls, Inc.

185,492

6,494,075

BUILDING PRODUCTS - 1.2%

Building Products - 1.2%

A.O. Smith Corp.

19,102

1,440,864

American Woodmark Corp. (a)

48,200

1,621,930

Armstrong World Industries, Inc.

48,988

2,500,348

 

5,563,142

COMMERCIAL SERVICES & SUPPLIES - 3.8%

Diversified Support Services - 0.6%

Aggreko PLC

110,600

3,061,485

Environmental & Facility Services - 3.2%

Republic Services, Inc.

328,843

11,206,969

Stericycle, Inc. (a)

33,034

3,578,243

 

14,785,212

TOTAL COMMERCIAL SERVICES & SUPPLIES

17,846,697

CONSTRUCTION & ENGINEERING - 3.0%

Construction & Engineering - 3.0%

EMCOR Group, Inc.

107,385

4,016,199

Jacobs Engineering Group, Inc. (a)

100,362

5,066,274

URS Corp.

113,211

4,972,227

 

14,054,700

ELECTRICAL EQUIPMENT - 7.9%

Electrical Components & Equipment - 7.9%

AMETEK, Inc.

171,700

6,989,907

Eaton Corp. PLC

232,833

14,298,275

Generac Holdings, Inc.

69,644

2,502,309

Hubbell, Inc. Class B

88,134

8,457,339

Regal-Beloit Corp.

55,717

4,380,471

 

36,628,301

INDUSTRIAL CONGLOMERATES - 23.1%

Industrial Conglomerates - 23.1%

3M Co.

197,356

20,665,147

Carlisle Companies, Inc.

79,194

5,137,315

Danaher Corp.

341,442

20,807,475

General Electric Co.

2,732,432

60,905,904

 

107,515,841

 

Shares

Value

LIFE SCIENCES TOOLS & SERVICES - 0.7%

Life Sciences Tools & Services - 0.7%

Eurofins Scientific SA

14,962

$ 3,251,194

MACHINERY - 28.6%

Construction & Farm Machinery & Heavy Trucks - 11.7%

Caterpillar, Inc.

176,486

14,943,070

Cummins, Inc.

107,454

11,432,031

Manitowoc Co., Inc.

353,124

6,624,606

Oshkosh Truck Corp. (a)

117,964

4,631,267

PACCAR, Inc.

131,315

6,536,861

Toro Co.

87,400

3,933,874

Wabtec Corp.

58,200

6,107,508

 

54,209,217

Industrial Machinery - 16.9%

Donaldson Co., Inc.

102,551

3,730,805

Dover Corp.

110,383

7,614,219

GEA Group AG

117,275

3,966,928

Graco, Inc.

90,226

5,461,380

Harsco Corp.

191,681

4,184,396

IDEX Corp.

88,851

4,622,918

Ingersoll-Rand PLC

156,787

8,435,141

Nordson Corp.

32,300

2,244,527

Pall Corp.

92,477

6,169,141

Parker Hannifin Corp.

91,094

8,068,196

Pentair Ltd.

128,496

6,983,758

Stanley Black & Decker, Inc.

93,202

6,972,442

Timken Co.

103,694

5,451,194

TriMas Corp. (a)

162,683

4,961,832

 

78,866,877

TOTAL MACHINERY

133,076,094

PROFESSIONAL SERVICES - 7.0%

Human Resource & Employment Services - 2.0%

Towers Watson & Co.

130,284

9,500,309

Research & Consulting Services - 5.0%

Bureau Veritas SA

19,303

2,365,432

Dun & Bradstreet Corp. (d)

119,566

10,575,613

Nielsen Holdings B.V.

149,604

5,179,290

Verisk Analytics, Inc. (a)

82,744

5,071,380

 

23,191,715

TOTAL PROFESSIONAL SERVICES

32,692,024

ROAD & RAIL - 3.3%

Railroads - 2.0%

Union Pacific Corp.

63,204

9,351,664

Common Stocks - continued

Shares

Value

ROAD & RAIL - CONTINUED

Trucking - 1.3%

Con-way, Inc.

49,631

$ 1,677,528

J.B. Hunt Transport Services, Inc.

62,044

4,409,467

 

6,086,995

TOTAL ROAD & RAIL

15,438,659

TRADING COMPANIES & DISTRIBUTORS - 3.6%

Trading Companies & Distributors - 3.6%

W.W. Grainger, Inc.

25,700

6,334,279

Watsco, Inc.

50,171

4,233,429

WESCO International, Inc. (a)

83,684

5,999,306

 

16,567,014

TOTAL COMMON STOCKS

(Cost $372,534,139)


462,516,684

Convertible Bonds - 0.5%

 

Principal Amount

 

BUILDING PRODUCTS - 0.5%

Building Products - 0.5%

Aspen Aerogels, Inc.:

8% 6/1/14 (e)

$ 1,177,234

1,177,234

8% 12/6/14 (e)

1,114,117

1,114,117

TOTAL CONVERTIBLE BONDS

(Cost $2,291,351)


2,291,351

U.S. Treasury Obligations - 0.0%

 

U.S. Treasury Bills, yield at date of purchase 0.05% 7/5/13
(Cost $89,992)

90,000


89,995

Money Market Funds - 0.8%

Shares

Value

Fidelity Cash Central Fund, 0.13% (b)

3,037,306

$ 3,037,306

Fidelity Securities Lending Cash Central Fund, 0.12% (b)(c)

451,250

451,250

TOTAL MONEY MARKET FUNDS

(Cost $3,488,556)


3,488,556

TOTAL INVESTMENT PORTFOLIO - 100.6%

(Cost $378,404,038)

468,386,586

NET OTHER ASSETS (LIABILITIES) - (0.6)%

(2,617,041 )

NET ASSETS - 100%

$ 465,769,545

Legend

(a) Non-income producing

(b) Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.

(c) Investment made with cash collateral received from securities on loan.

(d) Security or a portion of the security is on loan at period end.

(e) Restricted securities - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues). At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $2,291,351 or 0.5% of net assets.

Additional information on each restricted holding is as follows:

Security

Acquisition Date

Acquisition Cost

Aspen Aerogels, Inc. 8% 6/1/14

6/14/11 - 12/31/12

$ 1,177,234

Aspen Aerogels, Inc. 8% 12/6/14

12/6/11 - 12/31/12

$ 1,114,117

Affiliated Central Funds

Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:

Fund

Income earned

Fidelity Cash Central Fund

$ 15,239

Fidelity Securities Lending Cash Central Fund

499

Total

$ 15,738

Other Information

The following is a summary of the inputs used, as of April 30, 2013, involving the Fund's assets and liabilities carried at fair value. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. For more information on valuation inputs, and their aggregation into the levels used in the table below, please refer to the Investment Valuation section at the end of this listing.

Valuation Inputs at Reporting Date:

Description

Total

Level 1

Level 2

Level 3

Investments in Securities:

Common Stocks

$ 462,516,684

$ 462,516,684

$ -

$ -

Convertible Bonds

2,291,351

-

-

2,291,351

U.S. Treasury Obligations

89,995

-

89,995

-

Money Market Funds

3,488,556

3,488,556

-

-

Total Investments in Securities:

$ 468,386,586

$ 466,005,240

$ 89,995

$ 2,291,351

Income Tax Information

At April 30, 2013, the cost of investment securities for income tax purposes was $380,293,550. Net unrealized appreciation aggregated $88,093,036, of which $90,104,407 related to appreciated investment securities and $2,011,371 related to depreciated investment securities.

Investment Valuation

Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. In accordance with valuation policies and procedures approved by the Board of Trustees (the Board), the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Fidelity Management & Research Company (FMR) Fair Value Committee (the Committee), in accordance with procedures adopted by the Fund's Board. Factors used in determining fair value vary by investment type and may include market or investment specific events, changes in interest rates and credit quality. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund's valuation policies and procedures and is responsible for approving and reporting to the Board all fair value determinations. The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels: Level 1 - quoted prices in active markets for identical investments: Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds etc.): Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available). Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the Fund's investments by major category are as follows:

Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy in these circumstances. Utilizing these techniques may result in transfers between Level 1 and Level 2. For restricted equity securities and private placements where observable inputs are limited, assumptions about market activity and risk are used and these securities are generally categorized as Level 3 in the hierarchy.

Debt securities, including restricted securities, are valued based on evaluated prices received from third party pricing vendors or from brokers who make markets in such securities. For corporate bonds and U.S. government and government agency obligations, pricing vendors utilize matrix pricing which considers yield or price of bonds of comparable quality, coupon, maturity and type as well as broker-supplied prices.

When independent prices are unavailable or unreliable, debt securities may be valued utilizing pricing methodologies which consider similar factors that would be used by third party pricing vendors. Debt securities are generally categorized as Level 2 in the hierarchy but may be Level 3 depending on the circumstances.

Futures contracts are valued at the settlement price established each day by the board of trade or exchange on which they are traded and are categorized as Level 1 in the hierarchy. Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value each business day and are categorized as Level 1 in the hierarchy.

For additional information on the Fund's policy regarding valuation of investments and other significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.

Quarterly Report

The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please visit advisor.fidelity.com or call Fidelity at 1-877-208-0098 for a free copy of the fund's most recent prospectus and annual report.

Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.

Quarterly Report

Item 2. Controls and Procedures

(a)(i) The President and Treasurer and the Chief Financial Officer have concluded that the Fidelity Advisor Series VII's (the "Trust") disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act) provide reasonable assurances that material information relating to the Trust is made known to them by the appropriate persons, based on their evaluation of these controls and procedures as of a date within 90 days of the filing date of this report.

(a)(ii) There was no change in the Trust's internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act) that occurred during the Trust's last fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Trust's internal control over financial reporting.

Item 3. Exhibits

Certification pursuant to Rule 30a-2(a) under the Investment Company Act of 1940 (17 CFR 270.30a-2(a)) is filed and attached hereto as Exhibit 99.CERT.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Fidelity Advisor Series VII

By:

/s/Kenneth B. Robins

 

Kenneth B. Robins

 

President and Treasurer

 

 

Date:

June 28, 2013

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

By:

/s/Kenneth B. Robins

 

Kenneth B. Robins

 

President and Treasurer

 

 

Date:

June 28, 2013

By:

/s/Christine Reynolds

 

Christine Reynolds

 

Chief Financial Officer

 

 

Date:

June 28, 2013

Radian (NYSE:RDN)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024 Plus de graphiques de la Bourse Radian
Radian (NYSE:RDN)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024 Plus de graphiques de la Bourse Radian